RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | kidney failure |
|
Accession: | DOID:1074
|
browse the term
|
Definition: | A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood. (DO) |
Synonyms: | exact_synonym: | Kidney Insufficiencies; Kidney Insufficiency; Renal Failure; Renal Failures; Renal Insufficiencies; kidney failures; renal unsufficiency |
| primary_id: | MESH:D051437 |
| xref: | ICD10CM:N19; ICD9CM:586; NCI:C4376 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
GViewer not supported for the selected species.
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
ISO |
|
RGD |
PMID:10966936 |
RGD:13831124 |
NCBI chrNW_004955440:2,348,434...2,412,706
Ensembl chrNW_004955440:2,348,396...2,412,706
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32715474 |
|
NCBI chrNW_004955450:15,853,372...15,927,966
Ensembl chrNW_004955450:15,853,366...15,928,200
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9259580 |
|
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
|
RGD |
PMID:18046670 |
RGD:6904142 |
NCBI chrNW_004955419:13,478,904...13,492,329
Ensembl chrNW_004955419:13,478,552...13,492,327
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20842518 |
|
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:16893502 |
RGD:6902939 |
NCBI chrNW_004955427:19,237,251...19,274,001
Ensembl chrNW_004955427:19,236,445...19,261,517
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
DNA:polymorphism:5' utr:g.-94G>A (human) |
RGD |
PMID:19675531 |
RGD:7248447 |
NCBI chrNW_004955408:28,003,229...28,006,595
Ensembl chrNW_004955408:28,003,229...28,006,595
|
|
G |
Edn1 |
endothelin 1 |
onset |
ISO |
protein:increased expression:kidney (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:7967349 PMID:20888384 |
RGD:4144130 |
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22013135 |
|
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
treatment |
ISO |
associated with Ovarian Neoplasms;DNA:SNPs: :8092C>A, 19007T>C (human) |
RGD |
PMID:19786980 |
RGD:5688741 |
NCBI chrNW_004955555:2,393,510...2,430,180
Ensembl chrNW_004955555:2,393,278...2,406,582
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
associated with liver transplant; |
RGD |
PMID:18929838 |
RGD:9685774 |
NCBI chrNW_004955442:15,280,753...15,283,405
Ensembl chrNW_004955442:15,281,419...15,283,266
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
associated with Hypertension;protein:increased expression:kidney |
RGD |
PMID:15583217 |
RGD:1626324 |
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27469509 |
|
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3091246 PMID:8289579 |
|
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
mRNA, protein:increased expression:kidney (mouse) |
RGD |
PMID:20722564 PMID:21907489 |
RGD:7175305 RGD:7175345 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8606734 PMID:9861226 |
|
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
Kl |
klotho |
|
ISO |
|
RGD |
PMID:10892340 |
RGD:1581732 |
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29988851 |
|
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
|
|
G |
LOC102004641 |
cytochrome b-245 light chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23325087 |
|
NCBI chrNW_004955541:2,570,843...2,573,822
Ensembl chrNW_004955541:2,569,727...2,574,118
|
|
G |
LOC102013768 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8164439 |
|
NCBI chrNW_004955445:4,874,583...4,891,723
Ensembl chrNW_004955445:4,873,942...4,891,780
|
|
G |
Mefv |
MEFV innate immuity regulator, pyrin |
|
ISO |
ClinVar Annotator: match by term: Renal failure |
ClinVar |
PMID:1977178 PMID:9668175 PMID:10090880 PMID:10611954 PMID:10612841 PMID:10787450 PMID:10842288 PMID:11464238 PMID:11977178 PMID:15018633 PMID:15024744 PMID:16730661 PMID:17489852 PMID:19253030 PMID:19934083 PMID:20041150 PMID:20534143 PMID:21153919 PMID:21246368 PMID:21413889 PMID:21978701 PMID:22037353 PMID:22057232 PMID:22207183 PMID:22614345 PMID:22903357 PMID:23505242 PMID:23588594 PMID:23907647 PMID:23981758 PMID:24033266 PMID:24251727 PMID:24469716 PMID:24929125 PMID:25615955 PMID:25741868 PMID:26003477 PMID:26078663 PMID:26247045 PMID:27364639 PMID:27733942 PMID:28483595 PMID:28492532 PMID:29047407 PMID:29543225 PMID:29599418 PMID:31989427 PMID:32312770 PMID:33733382 More...
|
|
NCBI chrNW_004955442:14,068,436...14,093,889
Ensembl chrNW_004955442:14,068,348...14,094,016
|
|
G |
Mme |
membrane metalloendopeptidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10485324 |
|
NCBI chrNW_004955448:6,193,113...6,311,666
Ensembl chrNW_004955448:6,226,059...6,314,949
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
DNA:transition:cds:g.677C>T (human) |
RGD |
PMID:20433440 |
RGD:6893515 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
treatment |
ISO |
|
RGD |
PMID:25594614 |
RGD:13781896 |
NCBI chrNW_004955410:10,717,664...10,742,109
Ensembl chrNW_004955410:10,717,664...10,751,177
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32715474 |
|
NCBI chrNW_004955568:1,660,357...1,812,285
Ensembl chrNW_004955568:1,660,731...1,809,173
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23325087 |
|
NCBI chrNW_004955414:4,062,337...4,220,032
Ensembl chrNW_004955414:4,062,081...4,212,746
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
severity |
ISO |
protein:decreased expression:kidney (rat) |
RGD |
PMID:18346151 |
RGD:38599007 |
NCBI chrNW_004955468:2,715,728...2,734,174
Ensembl chrNW_004955468:2,714,419...2,734,830
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
|
RGD |
PMID:19833176 |
RGD:10413912 |
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
|
ISO |
mRNA:increased expression:parathroid gland,tibia: |
RGD |
PMID:14693675 |
RGD:11556273 |
NCBI chrNW_004955509:2,357,263...2,546,802
Ensembl chrNW_004955509:2,357,263...2,546,802
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Renal failure |
ClinVar |
|
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28182703 |
|
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
|
ISO |
|
RGD |
PMID:22076434 |
RGD:7242044 |
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
|
|
G |
Ren |
renin |
|
ISO |
|
RGD |
PMID:28533331 |
RGD:39939034 |
NCBI chrNW_004955406:40,016,624...40,026,286
Ensembl chrNW_004955406:40,016,630...40,026,286
|
|
G |
Rhcg |
Rh family C glycoprotein |
|
ISO |
protein:altered localization |
RGD |
PMID:17652373 |
RGD:9850158 |
NCBI chrNW_004955416:15,639,425...15,657,708
Ensembl chrNW_004955416:15,639,551...15,654,293
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:16828495 |
RGD:36174008 |
NCBI chrNW_004955481:1,414,930...1,426,436
Ensembl chrNW_004955481:1,414,930...1,426,241
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
mRNA, protein:decreased expression:kidney cortex |
RGD |
PMID:21167265 |
RGD:7243878 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Slco4c1 |
solute carrier organic anion transporter family member 4C1 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:14993604 |
RGD:1303977 |
NCBI chrNW_004955418:11,587,016...11,646,242
Ensembl chrNW_004955418:11,587,014...11,646,242
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
In type 2 diabetic patients |
RGD |
PMID:21034455 |
RGD:6903271 |
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
treatment |
ISO |
associated with Cholestasis; |
RGD |
PMID:9893136 |
RGD:11059601 |
NCBI chrNW_004955495:5,539,382...5,557,441
Ensembl chrNW_004955495:5,539,889...5,557,441
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:16177646 |
RGD:7241085 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16177646 PMID:27585667 |
RGD:7241085 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
severity |
ISO |
associated with Neoplasms, Plasma Cell |
RGD |
PMID:9650354 |
RGD:7245537 |
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
|
|
G |
Tsc1 |
TSC complex subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Renal failure |
ClinVar |
PMID:10227394 PMID:10570911 PMID:15798777 PMID:23341583 PMID:25741868 PMID:26467025 PMID:28492532 PMID:28968464 More...
|
|
NCBI chrNW_004955513:2,197,037...2,244,992
Ensembl chrNW_004955513:2,197,037...2,244,992
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
treatment |
ISO |
associated with endotoxemia; protein:increased expression:kidney associated with Endotoxemia; associated with Bacteremia; |
RGD |
PMID:14747378 PMID:19020966 PMID:19887504 |
RGD:7175276 RGD:7175281 RGD:7175283 |
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
|
RGD |
PMID:21811803 |
RGD:7243868 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Ahsg |
alpha 2-HS glycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955420:21,071,111...21,078,397
Ensembl chrNW_004955420:21,069,681...21,078,298
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO |
protein:decreased activity:kidney (rat) |
RGD |
PMID:19484701 |
RGD:4144146 |
NCBI chrNW_004955419:14,093,010...14,104,376
Ensembl chrNW_004955419:14,093,010...14,104,545
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2048579 PMID:21259293 PMID:24361871 PMID:28885000 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:19194548 |
RGD:2317536 |
NCBI chrNW_004955546:2,495,226...2,550,909
Ensembl chrNW_004955546:2,494,819...2,550,909
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8963945 PMID:28885000 |
RGD:6904218 |
NCBI chrNW_004955419:13,478,904...13,492,329
Ensembl chrNW_004955419:13,478,552...13,492,327
|
|
G |
Amn |
amnion associated transmembrane protein |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20514524 |
|
NCBI chrNW_004955538:2,017,476...2,021,890
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
|
RGD |
PMID:22101490 |
RGD:7421583 |
NCBI chrNW_004955512:5,686,508...5,703,645
|
|
G |
Ar |
androgen receptor |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
mRNA:decreased expression:renal tubule (rat) |
RGD |
PMID:12371970 |
RGD:631989 |
NCBI chrNW_004955436:12,235,767...12,247,817
Ensembl chrNW_004955436:12,235,767...12,251,972
|
|
G |
Arg2 |
arginase 2 |
|
ISO |
mRNA:decreased expression:renal tubule (rat) |
RGD |
PMID:12371970 |
RGD:631989 |
NCBI chrNW_004955466:2,549,557...2,577,060
Ensembl chrNW_004955466:2,549,557...2,577,060
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25666834 |
|
NCBI chrNW_004955458:4,188,167...4,195,575
Ensembl chrNW_004955458:4,186,461...4,195,494
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
|
ISO |
|
RGD |
PMID:17347933 |
RGD:2300348 |
NCBI chrNW_004955458:10,245,325...10,253,209
Ensembl chrNW_004955458:10,245,111...10,253,209
|
|
G |
B2m |
beta-2-microglobulin |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:2689182 PMID:19536607 PMID:22005293 PMID:28885000 |
RGD:6482685 |
NCBI chrNW_004955416:11,205,503...11,211,325
Ensembl chrNW_004955416:11,204,849...11,215,568
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
|
RGD |
PMID:20037173 |
RGD:10053672 |
NCBI chrNW_004955422:20,795,585...20,809,039
Ensembl chrNW_004955422:20,795,676...20,809,245
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20037173 PMID:20623750 |
RGD:10053672 |
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20037173 |
RGD:10053672 |
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bcl2l1 |
BCL2 like 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20037173 |
RGD:10053672 |
NCBI chrNW_004955422:29,254,440...29,307,104
Ensembl chrNW_004955422:29,254,216...29,308,174
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24975837 |
|
NCBI chrNW_004955438:16,514,300...16,537,160
Ensembl chrNW_004955438:16,511,759...16,537,172
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
Capn1 |
calpain 1 |
treatment |
ISO |
associated with Rhabdomyolysis; |
RGD |
PMID:24158126 |
RGD:13792553 |
NCBI chrNW_004955422:20,006,448...20,026,984
Ensembl chrNW_004955422:20,004,426...20,025,708
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:serum (mouse) |
RGD |
PMID:19508392 |
RGD:4889990 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31825490 |
|
NCBI chrNW_004955424:12,379,222...12,402,161
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23052191 |
|
NCBI chrNW_004955422:11,106,061...11,189,951
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:16557226 |
RGD:2293624 |
NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:urine |
CTD RGD |
PMID:20118187 PMID:20623750 PMID:22005293 PMID:22581811 PMID:23052191 PMID:24361871 PMID:28885000 More...
|
RGD:7245501 |
NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chrNW_004955435:13,404,236...13,423,059
Ensembl chrNW_004955435:13,404,508...13,424,247
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751
|
|
G |
Cst3 |
cystatin C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22005293 PMID:28885000 |
|
NCBI chrNW_004955415:30,507,972...30,512,109
|
|
G |
Ddit3 |
DNA damage inducible transcript 3 |
|
ISO |
Protein:increased expression:renal tubule epithelium |
RGD |
PMID:15476864 |
RGD:1599736 |
NCBI chrNW_004955458:5,232,979...5,238,513
Ensembl chrNW_004955458:5,232,979...5,238,513
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
ISO |
|
RGD |
PMID:10073607 PMID:11043448 |
RGD:7244180 RGD:7244185 |
NCBI chrNW_004955452:1,653,783...1,704,619
Ensembl chrNW_004955452:1,651,316...1,751,489
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:kidney (mouse) |
CTD RGD |
PMID:9788586 PMID:19967049 |
RGD:4144852 |
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
|
RGD |
PMID:20482449 |
RGD:6906908 |
NCBI chrNW_004955496:325,954...401,430
Ensembl chrNW_004955496:328,075...401,569
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic mRNA:increased expression:kidney |
CTD RGD |
PMID:11340354 PMID:14638913 |
RGD:10395241 |
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004955492:7,407,800...7,454,851
Ensembl chrNW_004955492:7,407,800...7,454,842
|
|
G |
Egln3 |
egl-9 family hypoxia inducible factor 3 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004955409:26,939,933...26,967,156
Ensembl chrNW_004955409:26,939,933...26,967,156
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
treatment |
ISO |
|
RGD |
PMID:16762988 |
RGD:10395386 |
NCBI chrNW_004955441:13,244,626...13,328,220
Ensembl chrNW_004955441:13,244,626...13,328,369
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26165641 |
|
NCBI chrNW_004955403:49,999,563...50,038,800
Ensembl chrNW_004955403:49,999,563...50,041,572
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21847101 PMID:22209169 PMID:22235348 PMID:24561306 |
RGD:10400913 RGD:11041660 |
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:renal tubule (rat) |
RGD |
PMID:21374789 |
RGD:8663469 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:15805072 |
RGD:9685024 |
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
|
|
G |
Fis1 |
fission, mitochondrial 1 |
|
ISO |
protein:decreased expression:kidney (rat) |
RGD |
PMID:26480480 |
RGD:12910862 |
NCBI chrNW_004955456:16,057,158...16,060,623
Ensembl chrNW_004955456:16,038,221...16,060,623
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:11768240 PMID:12884040 |
RGD:7205684 RGD:729934 |
NCBI chrNW_004955457:629,599...694,948
Ensembl chrNW_004955457:629,518...696,975
|
|
G |
Fstl1 |
follistatin like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20861081 |
|
NCBI chrNW_004955427:19,952,823...20,003,832
Ensembl chrNW_004955427:19,952,853...20,004,241
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:602954 PMID:734759 PMID:4794122 |
|
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
|
|
G |
Gas6 |
growth arrest specific 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19564549 |
|
NCBI chrNW_004955404:276,397...303,864
Ensembl chrNW_004955404:275,946...304,809
|
|
G |
Gatm |
glycine amidinotransferase |
|
ISO |
protein:decreased activity:kidney (rat) |
RGD |
PMID:2752493 |
RGD:1599823 |
NCBI chrNW_004955409:8,068,524...8,084,603
Ensembl chrNW_004955409:8,068,476...8,084,603
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
protein:increased expression:cortex of kidney,renal medulla: CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:20030531 |
RGD:9685736 |
NCBI chrNW_004955442:15,280,753...15,283,405
Ensembl chrNW_004955442:15,281,419...15,283,266
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
|
RGD |
PMID:19625378 |
RGD:7242430 |
NCBI chrNW_004955561:1,676,475...1,682,205
Ensembl chrNW_004955561:1,676,576...1,681,812
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
|
ISO |
protein:decreased activity:kidney (rat) |
RGD |
PMID:23924727 |
RGD:13506245 |
NCBI chrNW_004955433:16,121,795...16,145,129
Ensembl chrNW_004955433:16,122,824...16,145,113
|
|
G |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23052191 |
|
NCBI chrNW_004955410:25,554,279...25,583,368
Ensembl chrNW_004955410:25,553,973...25,582,500
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22785175 |
|
NCBI chrNW_004955427:19,489,972...19,671,137
Ensembl chrNW_004955427:19,495,422...19,671,137
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
protein:decreased activity:kidney: glycerol-induced |
RGD |
PMID:1870354 PMID:22286819 |
RGD:7257559 RGD:7257585 |
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20623750 PMID:20798258 |
RGD:6903954 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine associated with Pyelonephritis;protein:increased expression:urine: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20118187 PMID:21259293 PMID:21835770 PMID:22005293 PMID:23019274 PMID:23052191 PMID:23319831 PMID:23683031 PMID:23845967 PMID:24189134 PMID:24361871 PMID:24958931 PMID:28885000 More...
|
RGD:7244370 RGD:7245472 RGD:7245495 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Hbegf |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:kidney |
CTD RGD |
PMID:7635938 PMID:11340354 |
RGD:10395241 |
NCBI chrNW_004955418:259,860...321,340
Ensembl chrNW_004955418:309,096...321,387
|
|
G |
Hdac2 |
histone deacetylase 2 |
treatment |
ISO |
associated with sepsis; |
RGD |
PMID:22933299 |
RGD:9590257 |
NCBI chrNW_004955526:2,739,099...2,759,640
Ensembl chrNW_004955526:2,728,377...2,759,707
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
ISO |
|
RGD |
PMID:21416250 |
RGD:10047111 |
NCBI chrNW_004955415:12,138,520...12,154,234
Ensembl chrNW_004955415:12,138,870...12,154,234
|
|
G |
Hdac5 |
histone deacetylase 5 |
treatment |
ISO |
associated with sepsis; |
RGD |
PMID:21416250 PMID:22933299 |
RGD:10047111 RGD:9590257 |
NCBI chrNW_004955451:17,223,217...17,246,451
Ensembl chrNW_004955451:17,223,287...17,244,051
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
|
ISO |
protein:increased expression:kidney tubule (rat) mRNA:increased expression:kidney collecting duct (rat) |
RGD |
PMID:24325066 PMID:24397211 |
RGD:9685383 RGD:9685389 |
NCBI chrNW_004955420:14,565,921...14,568,447
Ensembl chrNW_004955420:14,564,283...14,568,447
|
|
G |
Hexb |
hexosaminidase subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22005293 |
|
NCBI chrNW_004955425:25,942,341...25,961,312
Ensembl chrNW_004955425:25,942,278...25,961,312
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
mRNA:increased expression:renal cortex (rat) |
RGD |
PMID:15673301 PMID:16762988 PMID:18593636 |
RGD:10395376 RGD:10395386 RGD:9068894 |
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
associated with Sepsis |
RGD |
PMID:16557230 |
RGD:5508471 |
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
CTD Direct Evidence: therapeutic associated with Sepsis |
CTD RGD |
PMID:21048024 PMID:23807243 |
RGD:10755583 |
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955414:22,158,654...22,169,133
Ensembl chrNW_004955414:22,156,819...22,169,631
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
protein:increased expression:kidney, lysosome (rat) |
RGD |
PMID:14966137 |
RGD:7242786 |
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:22659586 |
RGD:7175102 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7540432 |
|
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
mRNA: decreased expression: kidney: both cortex and medulla |
RGD |
PMID:9767523 |
RGD:7242908 |
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
|
|
G |
Igfbp1 |
insulin like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7540432 |
|
NCBI chrNW_004955456:6,810,461...6,814,944
Ensembl chrNW_004955456:6,810,056...6,815,685
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18460982 |
|
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:11342578 |
RGD:6893450 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:21716595 |
RGD:6907069 |
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
mRNA:increased expression:kidney, liver, spleen (mouse) protein:increased expression:kidney (rat) |
RGD |
PMID:21677145 PMID:22286667 PMID:22659586 PMID:22750969 |
RGD:7175094 RGD:7175102 RGD:7175258 RGD:7175314 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
associated with Sepsis associated with Asphyxia; rat model treated with human protein |
RGD |
PMID:14610321 PMID:16259926 PMID:16763508 |
RGD:6907360 RGD:6907369 RGD:6907375 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il20 |
interleukin 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18496552 |
|
NCBI chrNW_004955406:42,398,510...42,401,561
Ensembl chrNW_004955406:42,398,782...42,401,490
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
associated with Acute Lung Injury;protein:increased expression:plasma CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:18074478 PMID:21570986 |
RGD:5128661 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12243603 |
|
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
associated with Carcinoma, Lewis Lung, human cells in mouse model |
RGD |
PMID:31250048 |
RGD:149735351 |
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18227104 |
|
NCBI chrNW_004955559:457,030...461,086
Ensembl chrNW_004955559:456,932...465,704
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:513486 PMID:3015452 |
|
NCBI chrNW_004955420:20,989,197...21,016,084
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
|
|
G |
LOC102010322 |
cytochrome P450 1A2 |
treatment |
ISO |
|
RGD |
PMID:18495746 PMID:23981375 |
RGD:7257727 RGD:7257735 |
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
treatment |
ISO |
|
RGD |
PMID:18495746 PMID:19890363 |
RGD:7257732 RGD:7257735 |
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
LOC102011841 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial |
|
ISO |
|
RGD |
PMID:6223803 |
RGD:2307326 |
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
|
|
G |
LOC102021597 |
alpha-1-antiproteinase S-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955438:17,920,200...17,929,105
|
|
G |
LOC102021956 |
alpha-2-macroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23052191 |
|
NCBI chrNW_004955413:6,019,457...6,062,366
Ensembl chrNW_004955413:6,019,082...6,062,529
|
|
G |
LOC102026028 |
cytochrome P450 2E1 |
treatment |
ISO |
|
RGD |
PMID:24412858 PMID:24717297 |
RGD:14700914 RGD:14700920 |
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
|
|
G |
LOC102027549 |
serotransferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955501:4,801,710...4,832,025
Ensembl chrNW_004955501:4,801,885...4,831,910
|
|
G |
Lrg1 |
leucine rich alpha-2-glycoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34677723 |
|
NCBI chrNW_004955495:4,402,670...4,405,666
Ensembl chrNW_004955495:4,402,746...4,406,943
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29286200 |
|
NCBI chrNW_004955449:5,155,109...5,314,886
Ensembl chrNW_004955449:5,160,946...5,314,948
|
|
G |
Mb |
myoglobin |
|
ISO |
protein: increased expression: serum |
RGD |
PMID:9822635 PMID:23497406 |
RGD:7244253 RGD:7244259 |
NCBI chrNW_004955405:43,215,404...43,221,606
Ensembl chrNW_004955405:43,215,007...43,222,052
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
protein:increased expression:renal parenchyma (rat) |
RGD |
PMID:17940345 |
RGD:2317469 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mfn1 |
mitofusin 1 |
|
ISO |
protein:decreased expression:kidney (rat) |
RGD |
PMID:26480480 |
RGD:12910862 |
NCBI chrNW_004955420:8,541,547...8,596,494
Ensembl chrNW_004955420:8,541,936...8,594,437
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
DNA:haplotye: : CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19793022 PMID:20623750 PMID:22739978 |
RGD:6909168 RGD:6909185 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17387702 |
|
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:23022334 |
RGD:7245507 |
NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694
|
|
G |
Muc20 |
mucin 20, cell surface associated |
|
ISO |
|
RGD |
PMID:14565953 |
RGD:7364790 |
NCBI chrNW_004955420:12,212,666...12,234,213
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
susceptibility |
ISO |
protein:decreased phosphorylation:kidney (mouse) |
RGD |
PMID:23228991 |
RGD:7207407 |
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
|
RGD |
PMID:22160772 |
RGD:13801199 |
NCBI chrNW_004955485:9,607,781...9,613,123
Ensembl chrNW_004955485:9,607,781...9,613,151
|
|
G |
Nes |
nestin |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chrNW_004955545:2,748,132...2,756,595
Ensembl chrNW_004955545:2,748,078...2,756,301
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:24291173 PMID:24958931 |
RGD:10412697 |
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29286200 |
|
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
|
RGD |
PMID:14531809 |
RGD:13825139 |
NCBI chrNW_004955455:13,797,557...13,978,402
Ensembl chrNW_004955455:13,797,545...13,972,566
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9810145 |
|
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism in females;mRNA:increased expression:cortex of kidney (rat) |
CTD RGD |
PMID:9788586 PMID:28947737 |
RGD:13450947 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:kidney |
CTD RGD |
PMID:1825077 PMID:2948068 PMID:19298916 PMID:22209992 |
RGD:7247715 |
NCBI chrNW_004955486:2,061,196...2,062,805
Ensembl chrNW_004955486:2,060,735...2,063,003
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
associated with lung diseases;protein:increased expression:serum: associated with Myocardial Infarction;protein:increased expression:serum: associated with Pneumonia;protein:increased expression:serum: mRNA:increased expression:kidney |
RGD |
PMID:22209992 PMID:23192919 PMID:23415693 PMID:23837838 |
RGD:7247620 RGD:7247622 RGD:7247624 RGD:7247715 |
NCBI chrNW_004955486:2,054,775...2,056,130
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26723870 PMID:28230744 |
RGD:13440091 |
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Ocln |
occludin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19766176 |
|
NCBI chrNW_004955575:163,646...210,379
|
|
G |
Orm1 |
orosomucoid 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955419:13,262,119...13,264,986
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
|
RGD |
PMID:21884784 |
RGD:5510015 |
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
ISO |
protein:altered localization |
RGD |
PMID:12089381 |
RGD:7175293 |
NCBI chrNW_004955474:1,831,221...1,868,170
Ensembl chrNW_004955474:1,833,701...1,868,817
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:9767551 |
RGD:11541071 |
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955439:20,317,814...20,366,724
Ensembl chrNW_004955439:20,317,552...20,366,475
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17216604 |
|
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:17494862 PMID:20623750 PMID:24011919 PMID:24433871 |
RGD:8553020 |
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
|
ISO |
associated with Endotoxemia |
RGD |
PMID:21881206 |
RGD:7242026 |
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19092124 |
RGD:11250410 |
NCBI chrNW_004955459:3,097,229...3,105,566
Ensembl chrNW_004955459:3,094,120...3,104,135
|
|
G |
Procr |
protein C receptor |
treatment |
ISO |
associated with Sepsis |
RGD |
PMID:23807243 |
RGD:10755583 |
NCBI chrNW_004955422:26,215,757...26,220,396
Ensembl chrNW_004955422:26,216,002...26,220,101
|
|
G |
Ptafr |
platelet activating factor receptor |
treatment |
ISO |
associated with Endotoxemia |
RGD |
PMID:2538527 |
RGD:10043182 |
NCBI chrNW_004955452:7,309,854...7,345,579
Ensembl chrNW_004955452:7,311,901...7,312,929
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
ISO |
|
RGD |
PMID:16871242 |
RGD:10003092 |
NCBI chrNW_004955426:24,997,811...25,010,822
Ensembl chrNW_004955426:24,997,811...25,010,822
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:21893983 |
RGD:5508181 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Rapgef3 |
Rap guanine nucleotide exchange factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21745194 |
|
NCBI chrNW_004955500:6,655,056...6,674,311
Ensembl chrNW_004955500:6,655,056...6,674,311
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
associated with Sepsis;protein:increased phosphorylation:kidney |
RGD |
PMID:19428114 |
RGD:8547990 |
NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576
|
|
G |
Ren |
renin |
exacerbates |
ISO |
Associated with toxic shock syndrome;protein:increased expression:blood plasma (human) |
RGD |
PMID:30407370 |
RGD:125097506 |
NCBI chrNW_004955406:40,016,624...40,026,286
Ensembl chrNW_004955406:40,016,630...40,026,286
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
ISO |
associated with LPS induced endotoxemia |
RGD |
PMID:18824919 |
RGD:2313129 |
NCBI chrNW_004955599:688,414...690,644
|
|
G |
Serpinc1 |
serpin family C member 1 |
|
ISO |
associated with heart failure; protein:decreased activity:plasma: |
RGD |
PMID:26108065 |
RGD:11354006 |
NCBI chrNW_004955406:14,024,183...14,036,206
Ensembl chrNW_004955406:14,024,313...14,035,948
|
|
G |
Sirt1 |
sirtuin 1 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:kidney (rat) |
CTD RGD |
PMID:21416250 |
RGD:10047111 |
NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14655203 |
|
NCBI chrNW_004955422:20,555,458...20,561,818
Ensembl chrNW_004955422:20,556,098...20,596,012
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
treatment susceptibility |
ISO |
mRNA:decreased expression:kidney DNA:SNP: :808G>T (rs316019) human |
RGD |
PMID:18612803 PMID:19625999 PMID:22414646 |
RGD:7243179 RGD:7243880 RGD:7243884 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
disease_progression |
ISO |
associated with Sepsis; protein:decreased expression:renal proximal tubule (mouse) |
RGD |
PMID:19729856 |
RGD:7242943 |
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11274264 PMID:20623750 PMID:22863853 |
RGD:6903264 |
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
|
|
G |
Tff3 |
trefoil factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23052191 |
|
NCBI chrNW_004955407:39,398,534...39,401,085
Ensembl chrNW_004955407:39,398,074...39,401,248
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:11340354 |
RGD:10395241 |
NCBI chrNW_004955424:14,616,390...14,709,723
Ensembl chrNW_004955424:14,616,259...14,710,183
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10469268 |
|
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tgfbr1 |
transforming growth factor beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34677723 |
|
NCBI chrNW_004955419:26,490,899...26,546,349
Ensembl chrNW_004955419:26,490,899...26,547,017
|
|
G |
Thbd |
thrombomodulin |
treatment |
ISO |
|
RGD |
PMID:17804460 PMID:19176699 |
RGD:5684994 RGD:5685010 |
NCBI chrNW_004955415:30,222,830...30,226,406
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Sepsis |
CTD RGD |
PMID:22655058 PMID:29286200 |
RGD:7207898 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with Sepsis |
CTD RGD |
PMID:16638912 PMID:22266601 PMID:22655058 PMID:29286200 |
RGD:6892690 RGD:7207898 RGD:7241084 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tlr9 |
toll like receptor 9 |
|
ISO |
associated with Sepsis |
RGD |
PMID:23548820 |
RGD:7245966 |
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16595132 PMID:18460982 PMID:20623750 PMID:21150875 |
RGD:7245548 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23052191 |
|
NCBI chrNW_004955442:14,320,159...14,322,146
Ensembl chrNW_004955442:14,320,159...14,322,146
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
associated with Endotoxemia associated with Acute Lung Injury associated with Shock, Septic;protein:increased expression:serum |
RGD |
PMID:12023385 PMID:12500222 PMID:18074478 PMID:21150875 |
RGD:5128661 RGD:7245534 RGD:7245535 RGD:7245548 |
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
associated with Acute Lung Injury associated with Shock, Septic;protein:increased expression:serum |
RGD |
PMID:12500222 PMID:12865254 PMID:18074478 |
RGD:5128661 RGD:7245532 RGD:7245534 |
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20603111 |
|
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004955402:18,921,235...18,927,976
Ensembl chrNW_004955402:18,921,274...18,928,108
|
|
G |
Uts2r |
urotensin 2 receptor |
|
ISO |
|
RGD |
PMID:15146030 |
RGD:2306847 |
NCBI chrNW_004955506:756,859...761,891
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:20943766 PMID:22808199 |
|
NCBI chrNW_004955437:9,527,445...9,541,908
|
|
G |
Wnt4 |
Wnt family member 4 |
|
ISO |
|
RGD |
PMID:12707392 |
RGD:727218 |
NCBI chrNW_004955452:2,319,446...2,344,740
Ensembl chrNW_004955452:2,319,446...2,344,989
|
|
|
G |
Ak4 |
adenylate kinase 4 |
|
ISO |
protein:decreased expression:kidney (rat) |
RGD |
PMID:21152904 |
RGD:5134352 |
NCBI chrNW_004955423:25,395,086...25,402,324
Ensembl chrNW_004955423:25,395,836...25,427,474
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
|
ISO |
associated with Kidney Reperfusion Injury;protein:increased expression:kidney |
RGD |
PMID:16284088 |
RGD:1601494 |
NCBI chrNW_004955445:2,154,057...2,235,594
Ensembl chrNW_004955445:2,153,170...2,235,795
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31825490 |
|
NCBI chrNW_004955424:12,379,222...12,402,161
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:9422398 |
RGD:7242901 |
NCBI chrNW_004955442:7,600,903...7,647,619
Ensembl chrNW_004955442:7,603,893...7,647,624
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
protein:decreased activity:renal cortex: |
RGD |
PMID:12885594 PMID:17078987 |
RGD:7257555 RGD:7257573 |
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:kidney tubule, urine: |
RGD |
PMID:12081583 |
RGD:7245970 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Nog |
noggin |
|
ISO |
associated with Kidney Reperfusion Injury |
RGD |
PMID:16284088 |
RGD:1601494 |
NCBI chrNW_004955451:6,192,368...6,193,766
Ensembl chrNW_004955451:6,193,042...6,193,740
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:4358912 PMID:6254450 |
|
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19834340 |
|
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19917352 |
|
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
|
|
G |
Tek |
TEK receptor tyrosine kinase |
|
ISO |
associated with Kidney Reperfusion Injury |
RGD |
PMID:16284088 |
RGD:1601494 |
NCBI chrNW_004955472:7,633,790...7,748,130
Ensembl chrNW_004955472:7,633,721...7,748,386
|
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20190753 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
G |
Vps33b |
VPS33B late endosome and lysosome associated |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis with renal dysfunction and cholestasis syndrome |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955416:15,049,849...15,071,108
Ensembl chrNW_004955416:15,048,106...15,071,102
|
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955409:5,281,603...5,502,547
Ensembl chrNW_004955409:5,281,603...5,504,761
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 PMID:31319225 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
G |
Vps33b |
VPS33B late endosome and lysosome associated |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
OMIM ClinVar |
PMID:8151641 PMID:11668108 PMID:15052268 PMID:16896922 PMID:17994566 PMID:18853461 PMID:19274792 PMID:21851503 PMID:22753090 PMID:24782640 PMID:24917129 PMID:25741868 PMID:26505894 PMID:28492532 PMID:31479177 More...
|
|
NCBI chrNW_004955416:15,049,849...15,071,108
Ensembl chrNW_004955416:15,048,106...15,071,102
|
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 2 |
OMIM ClinVar |
PMID:20190753 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif 13 |
|
ISO |
ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
PMID:12753286 PMID:17187257 PMID:17627784 PMID:23715102 PMID:25741868 PMID:28492532 PMID:28748566 PMID:28866379 PMID:30046676 PMID:32183147 More...
|
|
NCBI chrNW_004955513:2,761,386...2,786,447
Ensembl chrNW_004955513:2,764,186...2,786,187
|
|
G |
Baat |
bile acid-CoA:amino acid N-acyltransferase |
|
ISO |
ClinVar Annotator: match by term: Hemolytic uremic syndrome, atypical, susceptibility to, 1 |
ClinVar |
|
|
NCBI chrNW_004955419:24,469,213...24,521,728
Ensembl chrNW_004955419:24,443,172...24,520,467
|
|
G |
C2 |
complement C2 |
|
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 4 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
PMID:2249879 PMID:6308626 PMID:8181962 PMID:16518403 PMID:16936732 PMID:18806293 PMID:20108004 PMID:20513133 PMID:21541267 PMID:22440158 PMID:24033266 PMID:24652797 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955437:449,171...460,898
Ensembl chrNW_004955437:448,672...460,519
|
|
G |
C3 |
complement C3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 4 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 5 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome | ClinVar Annotator: match by term: Familial Atypical Hemolytic-Uremic Syndrome |
OMIM ClinVar |
PMID:1976733 PMID:14639503 PMID:17634448 PMID:18325906 PMID:18796626 PMID:19168221 PMID:19590060 PMID:20301541 PMID:20595690 PMID:21125405 PMID:23307876 PMID:23314101 PMID:23431077 PMID:24036949 PMID:24036950 PMID:24036952 PMID:24736606 PMID:24845532 PMID:25188723 PMID:25608561 PMID:25741868 PMID:25951460 PMID:26283675 PMID:26613027 PMID:28492532 PMID:28596415 PMID:29566171 PMID:29888403 PMID:30046676 PMID:30131807 PMID:30773290 PMID:32950058 PMID:33213850 More...
|
|
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Hemolytic uremic syndrome, atypical, susceptibility to, 1 |
ClinVar |
|
|
NCBI chrNW_004955413:6,707,003...6,715,689
Ensembl chrNW_004955413:6,707,689...6,715,689
|
|
G |
Cd46 |
CD46 molecule |
susceptibility severity |
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 2 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 5 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome | ClinVar Annotator: match by term: Familial Atypical Hemolytic-Uremic Syndrome | ClinVar Annotator: match by term: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2 ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 1 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 2 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 5 | ClinVar Annotator: match by term: Atypical hemolytic uremic syndrome | ClinVar Annotator: match by term: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2 DNA:mutations:cds:multiple (human) |
OMIM ClinVar RGD |
PMID:270646 PMID:3480783 PMID:9551389 PMID:10528197 PMID:14566051 PMID:14615110 PMID:16621965 PMID:16762990 PMID:16882452 PMID:17089378 PMID:20059470 PMID:20513133 PMID:20595690 PMID:21706448 PMID:23431077 PMID:23731345 PMID:23780777 PMID:24033266 PMID:24161037 PMID:24247905 PMID:24944786 PMID:25381125 PMID:25525159 PMID:25741868 PMID:25899302 PMID:25951460 PMID:26054645 PMID:26307634 PMID:26559391 PMID:27399110 PMID:28056875 PMID:28492532 PMID:28509134 PMID:28752844 PMID:29500241 PMID:29566171 PMID:30305631 PMID:30609409 PMID:33224962 PMID:34169201 More...
|
RGD:11038684 |
NCBI chrNW_004955406:43,002,817...43,034,555
|
|
G |
Cfb |
complement factor B |
susceptibility |
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 4 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 5 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
OMIM ClinVar |
PMID:2249879 PMID:6308626 PMID:7452889 PMID:8181962 PMID:16518403 PMID:16936732 PMID:17182750 PMID:18806293 PMID:20108004 PMID:20513133 PMID:21541267 PMID:22440158 PMID:23847193 PMID:24033266 PMID:24652797 PMID:25741868 PMID:26054779 PMID:28492532 More...
|
|
NCBI chrNW_004955437:461,235...466,908
Ensembl chrNW_004955437:461,235...470,464
|
|
G |
Cfi |
complement factor I |
susceptibility |
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 3 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
OMIM ClinVar |
PMID:9536098 PMID:15173250 PMID:16621965 PMID:17576681 PMID:18557729 PMID:18825487 PMID:19877009 PMID:20016463 PMID:20106822 PMID:20203157 PMID:20513133 PMID:20595690 PMID:22710145 PMID:23307876 PMID:23314101 PMID:23431077 PMID:23685748 PMID:23787556 PMID:24033266 PMID:24034049 PMID:24036952 PMID:24161037 PMID:25037630 PMID:25135378 PMID:25352734 PMID:25741868 PMID:25741909 PMID:25758434 PMID:25788521 PMID:26691988 PMID:26767664 PMID:27268256 PMID:28282489 PMID:28492532 PMID:29392637 PMID:29410599 PMID:29500241 PMID:29888403 PMID:31049720 PMID:31249236 PMID:32510551 More...
|
|
NCBI chrNW_004955496:492,217...553,398
Ensembl chrNW_004955496:492,167...553,217
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
|
ISO |
ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
PMID:7599631 PMID:7695699 PMID:8218237 PMID:8651296 PMID:8940267 PMID:9848783 PMID:19344236 PMID:23720012 PMID:25741868 PMID:27627812 PMID:28492532 PMID:30577881 PMID:30773290 More...
|
|
NCBI chrNW_004955490:7,168,725...7,409,655
Ensembl chrNW_004955490:7,168,676...7,409,887
|
|
G |
Dgke |
diacylglycerol kinase epsilon |
|
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 5 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome | ClinVar Annotator: match by term: Hemolytic uremic syndrome, atypical, susceptibility to, 1 | ClinVar Annotator: match by term: Hemolytic uremic syndrome, atypical, susceptibility to, 7 |
ClinVar |
PMID:23542698 PMID:24511134 PMID:24747643 PMID:25741868 PMID:28492532 PMID:29590070 More...
|
|
NCBI chrNW_004955451:5,966,773...5,988,004
Ensembl chrNW_004955451:5,969,070...5,988,004
|
|
G |
Mmachc |
metabolism of cobalamin associated C |
|
ISO |
ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
PMID:16311595 PMID:16714133 PMID:17768669 PMID:17853453 PMID:18164228 PMID:19370762 PMID:19760748 PMID:20549364 PMID:20610126 PMID:20631720 PMID:23757202 PMID:23837176 PMID:24033266 PMID:24126030 PMID:24599607 PMID:25687216 PMID:25741868 PMID:25894566 PMID:28492532 PMID:29396438 More...
|
|
NCBI chrNW_004955464:12,774,018...12,780,612
Ensembl chrNW_004955464:12,772,420...12,780,612
|
|
G |
Plg |
plasminogen |
|
ISO |
ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
|
|
NCBI chrNW_004955439:20,317,814...20,366,724
Ensembl chrNW_004955439:20,317,552...20,366,475
|
|
G |
Smarcal1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 |
|
ISO |
ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955453:16,724,286...16,784,129
Ensembl chrNW_004955453:16,719,931...16,784,709
|
|
G |
Thbd |
thrombomodulin |
susceptibility severity no_association |
ISO |
ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 2 | ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 6 | ClinVar Annotator: match by term: Atypical hemolytic-uremic syndrome ClinVar Annotator: match by term: AHUS, SUSCEPTIBILITY TO, 6 | ClinVar Annotator: match by term: Atypical hemolytic uremic syndrome DNA:SNPs:5' utr, 3' utr:multiple |
OMIM ClinVar RGD |
PMID:7811989 PMID:9157575 PMID:9236408 PMID:10460600 PMID:11245641 PMID:11986219 PMID:12139752 PMID:15574195 PMID:17677000 PMID:19625716 PMID:20595690 PMID:23332921 PMID:24933457 PMID:25135378 PMID:25741868 PMID:28492532 PMID:34355501 More...
|
RGD:11038684 RGD:11038691 |
NCBI chrNW_004955415:30,222,830...30,226,406
|
|
|
G |
Ren |
renin |
|
ISO |
ClinVar Annotator: match by term: EARLY-ONSET HYPERURICEMIA, ANEMIA, AND PROGRESSIVE KIDNEY FAILURE | ClinVar Annotator: match by term: TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4 |
OMIM ClinVar |
PMID:16116425 PMID:19664745 PMID:25741868 PMID:28492532 PMID:32750457 PMID:33532864 More...
|
|
NCBI chrNW_004955406:40,016,624...40,026,286
Ensembl chrNW_004955406:40,016,630...40,026,286
|
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6338847 |
|
NCBI chrNW_004955406:40,016,624...40,026,286
Ensembl chrNW_004955406:40,016,630...40,026,286
|
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
susceptibility |
ISO |
protein:increased expression:kidney tubule: |
RGD |
PMID:22367506 PMID:23220287 |
RGD:7245477 RGD:7245950 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
|
G |
Aco1 |
aconitase 1 |
|
ISO |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chrNW_004955472:3,141,473...3,170,959
Ensembl chrNW_004955472:3,141,257...3,170,959
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:24370342 |
RGD:11035281 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Ccn2 |
cellular communication network factor 2 |
disease_progression |
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chrNW_004955436:12,523,602...12,526,986
Ensembl chrNW_004955436:12,522,944...12,526,480
|
|
G |
Clu |
clusterin |
treatment |
ISO |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
ISO |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chrNW_004955412:5,780,772...5,792,485
Ensembl chrNW_004955412:5,778,502...5,792,445
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004955460:8,328,400...8,346,755
Ensembl chrNW_004955460:8,326,891...8,346,550
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:11889420 PMID:15785371 |
RGD:10449491 RGD:11080974 |
NCBI chrNW_004955413:25,150,702...25,166,987
Ensembl chrNW_004955413:25,148,062...25,166,987
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004955447:16,570,652...16,613,410
Ensembl chrNW_004955447:16,569,909...16,612,373
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004955415:4,365,848...4,403,317
Ensembl chrNW_004955415:4,365,743...4,403,587
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600 RGD:13208601 |
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
|
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955468:770,573...841,859
Ensembl chrNW_004955468:770,573...842,209
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
disease_progression severity susceptibility |
ISO |
DNA:polymorphism:promoter:g.-374T>A (human) protein:increased expression:serum (human) DNA:polymorphisms:promoter, intron:g.-429T>C, g.2184A>G (human) associated with Diabetes Mellitus, Type 2; DNA:polymorphism:promoter:g.-429T>C (human) |
RGD |
PMID:20185929 PMID:20353610 PMID:21432860 PMID:21822023 PMID:23593165 |
RGD:7242570 RGD:7243185 RGD:7243867 RGD:7243958 RGD:7244142 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
disease_progression |
ISO |
DNA:polymorphism:3' utr:1166A>C (human) |
RGD |
PMID:12089373 PMID:12832734 |
RGD:6903863 RGD:8548869 |
NCBI chrNW_004955474:8,733,942...8,781,305
Ensembl chrNW_004955474:8,733,942...8,781,255
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
|
RGD |
PMID:12089373 |
RGD:6903863 |
NCBI chrNW_004955534:3,653,112...3,654,248
Ensembl chrNW_004955534:3,653,157...3,654,248
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
susceptibility |
ISO |
DNA:polymorphism: :rs756009(human) |
RGD |
PMID:19724895 |
RGD:14349027 |
NCBI chrNW_004955439:10,241,298...10,262,416
Ensembl chrNW_004955439:10,238,664...10,263,081
|
|
G |
Anln |
anillin actin binding protein |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955460:6,972,077...7,033,900
Ensembl chrNW_004955460:6,947,508...7,033,669
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Apoa4 |
apolipoprotein A4 |
disease_progression |
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:21569504 |
RGD:5685637 |
NCBI chrNW_004955412:18,158,095...18,160,636
Ensembl chrNW_004955412:18,155,801...18,160,701
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:21297177 PMID:21829457 |
RGD:7207207 RGD:7207209 |
NCBI chrNW_004955412:18,165,667...18,168,015
Ensembl chrNW_004955412:18,165,667...18,168,015
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955506:1,297,604...1,300,072
Ensembl chrNW_004955506:1,297,956...1,300,072
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955457:704,213...729,702
Ensembl chrNW_004955457:704,213...730,134
|
|
G |
Axdnd1 |
axonemal dynein light chain domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:8589695 PMID:10742096 PMID:11805166 PMID:15253708 PMID:15327385 PMID:18823551 PMID:19406966 PMID:20947785 PMID:21355056 PMID:24509478 PMID:24742477 PMID:25741868 PMID:28492532 PMID:30655312 PMID:32581362 More...
|
|
NCBI chrNW_004955406:18,717,383...18,859,263
Ensembl chrNW_004955406:18,717,820...18,858,905
|
|
G |
Cfi |
complement factor I |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955496:492,217...553,398
Ensembl chrNW_004955496:492,167...553,217
|
|
G |
Clu |
clusterin |
|
ISO |
associated with Obesity;protein:increased expression:urine |
RGD |
PMID:24325231 |
RGD:9068427 |
NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955404:2,196,193...2,327,324
Ensembl chrNW_004955404:2,260,029...2,326,074
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:14871398 PMID:17216251 PMID:24033266 PMID:24854265 PMID:25741868 PMID:26346198 PMID:26467025 PMID:27391953 PMID:28492532 PMID:29924831 PMID:30245029 More...
|
|
NCBI chrNW_004955453:7,261,278...7,351,414
|
|
G |
Col4a4 |
collagen type IV alpha 4 chain |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:12325029 PMID:21196518 PMID:24052634 PMID:24854265 PMID:25307543 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955453:7,405,167...7,524,038
Ensembl chrNW_004955453:7,420,203...7,520,200
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
DNA:polymorphism:cds :p.A147T(rs3742264)(human) |
RGD |
PMID:19056482 |
RGD:7243119 |
NCBI chrNW_004955518:3,740,348...3,803,540
Ensembl chrNW_004955518:3,740,348...3,803,539
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
ISO |
protein:decreased expression:liver: |
RGD |
PMID:23045433 |
RGD:10400847 |
NCBI chrNW_004955454:2,933,904...2,944,675
Ensembl chrNW_004955454:2,934,152...2,944,492
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
protein:decreased expression:liver: |
RGD |
PMID:23045433 |
RGD:10400847 |
NCBI chrNW_004955414:16,059,781...16,089,727
Ensembl chrNW_004955414:16,059,781...16,089,727
|
|
G |
Dnm1l |
dynamin 1 like |
treatment |
ISO |
|
RGD |
PMID:27801955 |
RGD:12738369 |
NCBI chrNW_004955505:3,025,742...3,081,491
Ensembl chrNW_004955505:3,023,018...3,081,680
|
|
G |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955406:40,922,972...40,971,433
Ensembl chrNW_004955406:40,922,972...40,971,582
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955558:1,032,743...1,046,300
Ensembl chrNW_004955558:1,032,743...1,046,300
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:22494291 |
RGD:10401925 |
NCBI chrNW_004955559:1,818,400...1,821,423
Ensembl chrNW_004955559:1,817,110...1,820,417
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:20016468 |
RGD:10044210 |
NCBI chrNW_004955413:2,182,459...2,192,279
Ensembl chrNW_004955413:2,182,459...2,192,279
|
|
G |
Fis1 |
fission, mitochondrial 1 |
treatment |
ISO |
|
RGD |
PMID:27801955 |
RGD:12738369 |
NCBI chrNW_004955456:16,057,158...16,060,623
Ensembl chrNW_004955456:16,038,221...16,060,623
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28166811 PMID:28492532 |
|
NCBI chrNW_004955457:629,599...694,948
Ensembl chrNW_004955457:629,518...696,975
|
|
G |
Frem1 |
FRAS1 related extracellular matrix 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955434:17,754,002...17,901,416
Ensembl chrNW_004955434:17,753,925...17,901,407
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955599:556,510...569,891
Ensembl chrNW_004955599:556,362...573,353
|
|
G |
Gja1 |
gap junction protein alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32045570 |
|
NCBI chrNW_004955436:3,612,533...3,618,095
Ensembl chrNW_004955436:3,612,533...3,618,095
|
|
G |
Gp1ba |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
|
RGD |
PMID:11314805 |
RGD:42722629 |
NCBI chrNW_004955467:10,333,537...10,347,488
Ensembl chrNW_004955467:10,333,575...10,346,989
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:15954914 |
RGD:11352759 |
NCBI chrNW_004955532:1,298,336...1,298,830
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:22269876 |
RGD:7245952 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:12841361 |
RGD:1300058 |
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24714768 |
|
NCBI chrNW_004955406:42,376,102...42,384,902
Ensembl chrNW_004955406:42,376,104...42,384,902
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:decreased expression:serum (human) mRNA:increased expression:kidney (mouse) associated with Periodontitis; DNA:SNP:intron:g.3954C>T (human) |
RGD |
PMID:21975861 PMID:22398717 PMID:22613545 PMID:22728154 PMID:22795294 |
RGD:6906881 RGD:7175095 RGD:7175169 RGD:7175171 RGD:7175304 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup IL1RN*1 (human) protein:increased expression:plasma (human) |
RGD |
PMID:22795294 PMID:23024164 |
RGD:6906880 RGD:6906881 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Inf2 |
inverted formin 2 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955538:3,154,670...3,176,510
Ensembl chrNW_004955538:3,163,940...3,178,832
|
|
G |
Insr |
insulin receptor |
|
ISO |
protein:decreased phosphorylation:aorta |
RGD |
PMID:22942179 |
RGD:7207055 |
NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149
|
|
G |
Kl |
klotho |
disease_progression treatment |
ISO |
protein:decreased expression:urine: mRNA,protein:decreased expression:renal tubule, epithelial cell: protein:decreased expression:urine,plasma,kidney: |
RGD |
PMID:11967236 PMID:21115613 |
RGD:10403077 RGD:70544 |
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
|
|
G |
Klk1 |
kallikrein 1 |
susceptibility |
ISO |
associated with Vesico-Ureteral Reflux |
RGD |
PMID:15086490 |
RGD:1581752 |
NCBI chrNW_004955559:457,030...461,086
Ensembl chrNW_004955559:456,932...465,704
|
|
G |
Lepr |
leptin receptor |
|
ISO |
|
RGD |
PMID:27465994 PMID:32390513 |
RGD:12911217 RGD:34888223 |
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
|
|
G |
Mfn1 |
mitofusin 1 |
treatment |
ISO |
|
RGD |
PMID:27801955 |
RGD:12738369 |
NCBI chrNW_004955420:8,541,547...8,596,494
Ensembl chrNW_004955420:8,541,936...8,594,437
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism:cds:g.677C>T (human) |
RGD |
PMID:23595572 |
RGD:7244284 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Myh9 |
myosin heavy chain 9 |
no_association |
ISO |
|
RGD |
PMID:22956460 |
RGD:12798515 |
NCBI chrNW_004955413:22,881,759...22,972,182
Ensembl chrNW_004955413:22,881,045...22,972,450
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:23174956 |
RGD:10412711 |
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24244623 |
|
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment susceptibility |
ISO |
mRNA:decreased expression:cortex of kidney (rat) |
RGD |
PMID:29018182 PMID:29247650 |
RGD:13450920 RGD:13504713 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
severity |
ISO |
mRNA:increased expression:urine (human) |
RGD |
PMID:30133147 |
RGD:38549368 |
NCBI chrNW_004955468:2,715,728...2,734,174
Ensembl chrNW_004955468:2,714,419...2,734,830
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:8589695 PMID:10742096 PMID:11729243 PMID:11805166 PMID:11854170 PMID:12649741 PMID:14570703 PMID:14675423 PMID:14978175 PMID:15253708 PMID:15327385 PMID:17371932 PMID:17942957 PMID:18216321 PMID:18443213 PMID:18823551 PMID:19371226 PMID:19406966 PMID:20798252 PMID:20947785 PMID:21171529 PMID:21355056 PMID:21415313 PMID:23242530 PMID:24089165 PMID:24227627 PMID:24500309 PMID:24509478 PMID:24742477 PMID:24856380 PMID:25349199 PMID:25741868 PMID:25852895 PMID:26467025 PMID:28492532 PMID:28780565 PMID:29049388 PMID:29127259 PMID:29382718 PMID:29982877 PMID:30655312 PMID:32129207 PMID:32581362 More...
|
|
NCBI chrNW_004955406:18,862,054...18,885,214
Ensembl chrNW_004955406:18,863,446...18,885,279
|
|
G |
Nppa |
natriuretic peptide A |
disease_progression |
ISO |
protein:increased expression:plasma |
RGD |
PMID:19052536 |
RGD:7247723 |
NCBI chrNW_004955486:2,061,196...2,062,805
Ensembl chrNW_004955486:2,060,735...2,063,003
|
|
G |
Nppb |
natriuretic peptide B |
disease_progression |
ISO |
|
RGD |
PMID:23725445 |
RGD:7246908 |
NCBI chrNW_004955486:2,054,775...2,056,130
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:22227174 |
RGD:10769366 |
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4 group A member 1 |
disease_progression |
ISO |
|
RGD |
PMID:24722447 |
RGD:12910103 |
NCBI chrNW_004955547:2,404,532...2,426,882
Ensembl chrNW_004955547:2,404,532...2,431,050
|
|
G |
Opa1 |
OPA1 mitochondrial dynamin like GTPase |
treatment |
ISO |
|
RGD |
PMID:27801955 |
RGD:12738369 |
NCBI chrNW_004955420:14,927,490...15,007,082
Ensembl chrNW_004955420:14,923,575...15,007,081
|
|
G |
Pask |
PAS domain containing serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955542:539,806...578,496
Ensembl chrNW_004955542:555,030...578,227
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
ISO |
|
RGD |
PMID:18039782 |
RGD:6483556 |
NCBI chrNW_004955415:26,266,513...26,496,905
Ensembl chrNW_004955415:26,266,484...26,497,001
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Postn |
periostin |
|
ISO |
protein:increased expression:kidney: protein:increased secretion:urine: |
RGD |
PMID:22167593 PMID:22403621 |
RGD:10040972 RGD:10041032 |
NCBI chrNW_004955431:8,510,646...8,544,901
Ensembl chrNW_004955431:8,510,624...8,544,971
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
|
ISO |
|
RGD |
PMID:22648295 |
RGD:7242023 |
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
|
|
G |
Pth |
parathyroid hormone |
treatment severity |
ISO |
associated with Diabetes Mellitus, Type 2; protein:increased expression:serum (human) protein:decreased expression:plasma (rat) |
RGD |
PMID:21826734 PMID:22517117 PMID:23345625 PMID:23467111 PMID:23528898 |
RGD:7242412 RGD:7242418 RGD:7242572 RGD:7242935 RGD:7242949 |
NCBI chrNW_004955414:28,828,389...28,831,417
Ensembl chrNW_004955414:28,825,651...28,831,117
|
|
G |
Retn |
resistin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22421264 |
|
NCBI chrNW_004955563:1,607,814...1,609,273
Ensembl chrNW_004955563:1,607,814...1,609,273
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
protein, activity:decreased expression:plasma, heart, kidney: |
RGD |
PMID:18299506 |
RGD:7327164 |
NCBI chrNW_004955425:4,368,620...4,667,947
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chrNW_004955491:8,647,133...8,657,381
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
mRNA:decreased expression:multiple (rat) |
RGD |
PMID:21149507 |
RGD:7327184 |
NCBI chrNW_004955407:42,132,216...42,154,252
Ensembl chrNW_004955407:42,132,165...42,141,992
|
|
G |
Slc19a2 |
solute carrier family 19 member 2 |
|
ISO |
mRNA:decreased expression:liver, heart (rat) |
RGD |
PMID:21149507 |
RGD:7327184 |
NCBI chrNW_004955462:7,786,920...7,804,828
Ensembl chrNW_004955462:7,786,913...7,805,792
|
|
G |
Slc19a3 |
solute carrier family 19 member 3 |
|
ISO |
mRNA:decreased expression:liver, heart, jejunum (rat) |
RGD |
PMID:21149507 |
RGD:7327184 |
NCBI chrNW_004955453:6,935,372...6,957,808
Ensembl chrNW_004955453:6,935,371...6,958,103
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
DNA:snp:intron:IVS9+122A>G rs6420094 (human) mRNA:decreased expression:kidney (rat) |
RGD |
PMID:20383146 PMID:21826734 |
RGD:7242935 RGD:7243100 |
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
|
|
G |
Slc46a1 |
solute carrier family 46 member 1 |
|
ISO |
mRNA:decreased expression:liver, heart, jejunum (rat) |
RGD |
PMID:21149507 |
RGD:7327184 |
NCBI chrNW_004955481:4,735,325...4,741,810
Ensembl chrNW_004955481:4,734,967...4,745,586
|
|
G |
Slc9a3r1 |
SLC9A3 regulator 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:18784102 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955553:1,639,267...1,656,850
Ensembl chrNW_004955553:1,639,267...1,656,850
|
|
G |
Tbx18 |
T-box transcription factor 18 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955411:12,194,560...12,232,374
Ensembl chrNW_004955411:12,194,550...12,232,374
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:23013219 |
RGD:11038770 |
NCBI chrNW_004955504:649,248...669,796
Ensembl chrNW_004955504:651,779...670,589
|
|
G |
Tfcp2l1 |
transcription factor CP2 like 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:33097957 |
|
NCBI chrNW_004955459:8,657,188...8,716,878
Ensembl chrNW_004955459:8,657,188...8,717,133
|
|
G |
Tlr9 |
toll like receptor 9 |
susceptibility |
ISO |
DNA:SNPs:promoter, exon:g.-1237T>C, g.1635G>A (rs5743836, rs352140) (human, Han Chinese) |
RGD |
PMID:21908957 |
RGD:7246887 |
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
|
|
G |
Ttc21b |
tetratricopeptide repeat domain 21B |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955449:8,242,327...8,306,012
Ensembl chrNW_004955449:8,241,990...8,308,562
|
|
G |
Umod |
uromodulin |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955442:3,986,936...4,001,155
Ensembl chrNW_004955442:3,985,308...3,999,598
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:serum: protein:increased expression:kidney |
RGD |
PMID:20820841 PMID:21111939 |
RGD:4145364 RGD:7241036 |
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
|
|
G |
Wnt9b |
Wnt family member 9B |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:34145744 |
|
NCBI chrNW_004955478:10,816,405...10,841,416
Ensembl chrNW_004955478:10,816,405...10,841,416
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955476:10,464,688...10,504,473
Ensembl chrNW_004955476:10,464,616...10,504,473
|
|
G |
Znf423 |
zinc finger protein 423 |
|
ISO |
ClinVar Annotator: match by term: Chronic kidney disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955433:7,700,965...8,018,437
Ensembl chrNW_004955433:7,700,734...8,009,451
|
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:27781957 |
RGD:13782262 |
NCBI chrNW_004955403:24,315,712...24,326,271
|
|
G |
Ddit3 |
DNA damage inducible transcript 3 |
treatment |
ISO |
|
RGD |
PMID:27781957 |
RGD:13782262 |
NCBI chrNW_004955458:5,232,979...5,238,513
Ensembl chrNW_004955458:5,232,979...5,238,513
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
ISO |
mRNA,protein:increased expression:kidney medulla |
RGD |
PMID:18385664 |
RGD:7243946 |
NCBI chrNW_004955452:1,653,783...1,704,619
Ensembl chrNW_004955452:1,651,316...1,751,489
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23335628 |
RGD:7245471 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
treatment |
ISO |
|
RGD |
PMID:27781957 |
RGD:13782262 |
NCBI chrNW_004955419:3,055,420...3,060,208
Ensembl chrNW_004955419:3,055,420...3,062,131
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:22094062 |
RGD:7175334 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
treatment |
ISO |
|
RGD |
PMID:27781957 |
RGD:13782262 |
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
|
RGD |
PMID:20722568 |
RGD:6909183 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:19298916 |
RGD:7247719 |
NCBI chrNW_004955486:2,061,196...2,062,805
Ensembl chrNW_004955486:2,060,735...2,063,003
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
associated with Heart Failure |
RGD |
PMID:20438292 |
RGD:7248591 |
NCBI chrNW_004955486:2,054,775...2,056,130
|
|
|
G |
Gp1ba |
glycoprotein Ib platelet subunit alpha |
|
ISO |
associated with Escherichia Coli Infections;DNA:SNP:exon: (rs121908064) (human) |
RGD |
PMID:29216383 |
RGD:42722620 |
NCBI chrNW_004955467:10,333,537...10,347,488
Ensembl chrNW_004955467:10,333,575...10,346,989
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
|
RGD |
PMID:17135344 |
RGD:2301067 |
NCBI chrNW_004955432:4,911,774...5,085,349
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:17135344 |
RGD:2301067 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
|
ISO |
protein:decreased expression:intestine |
RGD |
PMID:17135344 |
RGD:2301067 |
NCBI chrNW_004955451:11,087,246...11,130,108
Ensembl chrNW_004955451:11,087,570...11,130,482
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955407:39,410,262...39,459,383
Ensembl chrNW_004955407:39,410,262...39,459,383
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
ISO |
protein:increased expression:kidney (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19878707 |
RGD:2326081 |
NCBI chrNW_004955412:10,350,088...10,369,806
Ensembl chrNW_004955412:10,349,593...10,369,806
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum, urine CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19539174 PMID:24028144 |
RGD:8695941 |
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
|
|
G |
Adipor1 |
adiponectin receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19539174 PMID:24028144 |
RGD:8695941 |
NCBI chrNW_004955406:38,939,167...38,955,647
Ensembl chrNW_004955406:38,936,588...38,955,352
|
|
G |
Adipor2 |
adiponectin receptor 2 |
|
ISO |
|
RGD |
PMID:24028144 |
RGD:8695941 |
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:9730702 |
RGD:7175286 |
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:21822023 |
RGD:7243867 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
associated with Vesico-Ureteral Reflux;DNA:SNP: :-1332A>G (human) |
RGD |
PMID:19212419 PMID:20149750 |
RGD:6903283 RGD:6903843 |
NCBI chrNW_004955534:3,653,112...3,654,248
Ensembl chrNW_004955534:3,653,157...3,654,248
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11849406 PMID:11938814 |
RGD:11036089 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
associated with Hyperlipidemias protein:decreased expression:blood protein:increased expression, increased glycation:plasma |
RGD |
PMID:18079481 PMID:20488818 PMID:22515595 |
RGD:7241208 RGD:7241571 RGD:7241576 |
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
associated with Diabetes Mellitus, Insulin-Dependent |
RGD |
PMID:8139482 |
RGD:2313968 |
NCBI chrNW_004955555:2,019,547...2,021,543
Ensembl chrNW_004955555:2,016,217...2,021,830
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:increased expression: : associated with Diabetes Mellitus, Insulin-Dependent |
RGD |
PMID:8139482 PMID:10822722 |
RGD:2313968 RGD:7207212 |
NCBI chrNW_004955412:18,165,667...18,168,015
Ensembl chrNW_004955412:18,165,667...18,168,015
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:21332332 PMID:21705678 |
RGD:6903287 RGD:6904217 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Arg2 |
arginase 2 |
|
ISO |
protein:decreased activity:kidney (rat) |
RGD |
PMID:16809898 |
RGD:4110828 |
NCBI chrNW_004955466:2,549,557...2,577,060
Ensembl chrNW_004955466:2,549,557...2,577,060
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:20424483 |
RGD:11522730 |
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
no_association resistance |
ISO |
DNA: SNP: G(-699)C DNA: SNP: G-699-->C |
RGD |
PMID:9555662 PMID:10604543 PMID:10809796 |
RGD:7241560 RGD:7241561 RGD:7241582 |
NCBI chrNW_004955438:16,500,219...16,505,394
Ensembl chrNW_004955438:16,500,633...16,501,691
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:24090408 |
RGD:11561926 |
NCBI chrNW_004955451:16,616,595...16,625,731
Ensembl chrNW_004955451:16,616,595...16,625,730
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17365904 PMID:20845051 |
RGD:7207235 RGD:7207409 |
NCBI chrNW_004955545:2,381,091...2,382,114
Ensembl chrNW_004955545:2,381,156...2,381,978
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:24090408 |
RGD:11561926 |
NCBI chrNW_004955477:9,621,812...9,630,406
Ensembl chrNW_004955477:9,621,812...9,638,099
|
|
G |
Casr |
calcium sensing receptor |
|
ISO |
protein:decreased expression:epigastric artery (human) |
RGD |
PMID:17537980 |
RGD:7205455 |
NCBI chrNW_004955427:21,486,608...21,574,017
Ensembl chrNW_004955427:21,486,427...21,575,210
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein: decreased expression :kidney |
CTD RGD |
PMID:16518626 PMID:19420110 PMID:20007347 |
RGD:6892947 |
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
|
|
G |
Cbr1 |
carbonyl reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26282591 |
|
NCBI chrNW_004955407:35,351,601...35,354,510
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:kidney cortex (rat) |
RGD |
PMID:19535570 |
RGD:4889989 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Cd40 |
CD40 molecule |
treatment severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:12941150 PMID:20846521 |
RGD:7248709 RGD:7248723 |
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19019166 |
RGD:7248427 |
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Cd68 |
CD68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19539174 |
|
NCBI chrNW_004955467:9,340,490...9,343,912
Ensembl chrNW_004955467:9,341,364...9,343,836
|
|
G |
Cfb |
complement factor B |
severity |
ISO |
|
RGD |
PMID:1837062 PMID:17522263 |
RGD:7242704 RGD:7242753 |
NCBI chrNW_004955437:461,235...466,908
Ensembl chrNW_004955437:461,235...470,464
|
|
G |
Chga |
chromogranin A |
|
ISO |
associated with Hypertension;DNA:polymorphisms, haplotypes:promoter, 3' utr:multiple protein:increased expression:serum |
RGD |
PMID:18235090 PMID:20730520 |
RGD:6906898 RGD:6906903 |
NCBI chrNW_004955438:15,092,267...15,104,321
Ensembl chrNW_004955438:15,092,394...15,104,381
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
|
RGD |
PMID:25782334 |
RGD:11041185 |
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
DNA:polymorphism: :p.I1205V (human) |
RGD |
PMID:19424605 |
RGD:7257553 |
NCBI chrNW_004955403:9,720,831...9,758,019
Ensembl chrNW_004955403:9,721,114...9,757,887
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
|
ISO |
|
RGD |
PMID:19357112 |
RGD:7242047 |
NCBI chrNW_004955453:7,261,278...7,351,414
|
|
G |
Col4a4 |
collagen type IV alpha 4 chain |
|
ISO |
ClinVar Annotator: match by term: Stage 5 chronic kidney disease |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955453:7,405,167...7,524,038
Ensembl chrNW_004955453:7,420,203...7,520,200
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955422:17,105,887...17,159,696
Ensembl chrNW_004955422:17,109,256...17,159,838
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:11340249 |
RGD:7257586 |
NCBI chrNW_004955435:13,404,236...13,423,059
Ensembl chrNW_004955435:13,404,508...13,424,247
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
associated with Wegener Granulomatosis;DNA:polymorphisms:promoter,exon::-318C>T, (AT)repeats (human) |
RGD |
PMID:15708894 |
RGD:7204725 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:20649681 |
RGD:7207863 |
NCBI chrNW_004955453:15,181,027...15,196,224
Ensembl chrNW_004955453:15,194,205...15,195,272
|
|
G |
Ddc |
dopa decarboxylase |
|
ISO |
protein:altered activity:renal cortex (rat) |
RGD |
PMID:19167406 |
RGD:5128880 |
NCBI chrNW_004955456:3,513,779...3,582,851
Ensembl chrNW_004955456:3,513,042...3,582,911
|
|
G |
Drd1 |
dopamine receptor D1 |
treatment |
ISO |
|
RGD |
PMID:18402547 |
RGD:7248448 |
NCBI chrNW_004955408:28,003,229...28,006,595
Ensembl chrNW_004955408:28,003,229...28,006,595
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin Dependent; DNA:polymorphisms:5'utr, intron: -141delC, G>A (human) |
RGD |
PMID:18366720 |
RGD:2311602 |
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:8441230 |
RGD:4144849 |
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
ISO |
Associated with Type 2 diabetes |
RGD |
PMID:18184924 |
RGD:6906927 |
NCBI chrNW_004955436:12,416,147...12,477,214
Ensembl chrNW_004955436:12,415,737...12,480,359
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
disease_progression |
ISO |
|
RGD |
PMID:20694143 |
RGD:5688726 |
NCBI chrNW_004955403:49,999,563...50,038,800
Ensembl chrNW_004955403:49,999,563...50,041,572
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16707910 |
|
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
protein:decreased expression:heart |
RGD |
PMID:27468524 |
RGD:11532749 |
NCBI chrNW_004955495:2,293,587...2,299,302
Ensembl chrNW_004955495:2,293,540...2,298,715
|
|
G |
F2 |
coagulation factor II, thrombin |
treatment |
ISO |
|
RGD |
PMID:22473220 |
RGD:7387323 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
F5 |
coagulation factor V |
|
ISO |
DNA:mutation: :1691G>A(human) |
RGD |
PMID:19520684 |
RGD:6893522 |
NCBI chrNW_004955462:7,695,004...7,757,832
Ensembl chrNW_004955462:7,694,939...7,757,463
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
|
ISO |
DNA:polymorphism:CDS:amino acid A54T, associated with Diabetes Mellitus, Type 2 (MeSH:D003924) |
RGD |
PMID:16249461 |
RGD:1578457 |
NCBI chrNW_004955428:20,930,512...20,933,950
Ensembl chrNW_004955428:20,930,479...20,933,950
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955506:1,063,002...1,079,939
Ensembl chrNW_004955506:1,063,002...1,079,939
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:15266033 |
RGD:7240530 |
NCBI chrNW_004955462:14,639,396...14,653,801
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
ISO |
associated with hypertension;DNA:polymorphism: :-455G>A (human) |
RGD |
PMID:19352213 |
RGD:7175505 |
NCBI chrNW_004955471:8,824,901...8,832,836
Ensembl chrNW_004955471:8,822,965...8,832,884
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:6665521 |
RGD:7205701 |
NCBI chrNW_004955457:629,599...694,948
Ensembl chrNW_004955457:629,518...696,975
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
ClinVar Annotator: match by term: Stage 5 chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955421:24,448,446...24,477,885
Ensembl chrNW_004955421:24,457,496...24,478,744
|
|
G |
Gckr |
glucokinase regulator |
|
ISO |
DNA: snp: rs1260326 |
RGD |
PMID:21980298 |
RGD:7242279 |
NCBI chrNW_004955469:9,461,541...9,485,034
Ensembl chrNW_004955469:9,461,848...9,484,707
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
|
RGD |
PMID:18809976 |
RGD:7242553 |
NCBI chrNW_004955561:1,676,475...1,682,205
Ensembl chrNW_004955561:1,676,576...1,681,812
|
|
G |
Glo1 |
glyoxalase I |
severity |
ISO |
DNA:SNP: :419C>A (human) |
RGD |
PMID:20185929 |
RGD:7242570 |
NCBI chrNW_004955437:4,728,709...4,749,834
Ensembl chrNW_004955437:4,728,709...4,749,834
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
protein:increased activity:lymphocyte: protein:increased activity:blood: |
RGD |
PMID:6463365 PMID:20181004 |
RGD:7257547 RGD:7257560 |
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
|
|
G |
Gtpbp4 |
GTP binding protein 4 |
|
ISO |
|
RGD |
PMID:11316846 |
RGD:632611 |
NCBI chrNW_004955492:5,594...33,558
Ensembl chrNW_004955492:5,594...34,111
|
|
G |
Guca2b |
guanylate cyclase activator 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15780094 |
|
NCBI chrNW_004955537:1,798,249...1,801,673
Ensembl chrNW_004955537:1,798,249...1,801,673
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:plasma |
RGD CTD |
PMID:16929540 PMID:19212416 PMID:20631677 |
RGD:11041611 RGD:11041622 |
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
|
|
G |
Hbegf |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21937979 |
|
NCBI chrNW_004955418:259,860...321,340
Ensembl chrNW_004955418:309,096...321,387
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
associated with Hypertension CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19878707 PMID:21119529 |
RGD:5508686 |
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22622455 |
|
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:20820841 |
RGD:4145364 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10198369 |
|
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
|
|
G |
Il1a |
interleukin 1 alpha |
no_association |
ISO |
DNA:SNPs, deletion, haplotypes:3' utr:multiple (human) DNA:SNP, insertion/deletion:intron, 3' utr:rs1516792-3, rs16347-2 (human) |
RGD |
PMID:12631337 PMID:12837270 PMID:20551628 |
RGD:6907070 RGD:6907105 RGD:6907106 |
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il1b |
interleukin 1 beta |
no_association |
ISO |
protein:increased expression:plasma (rat) DNA:SNP |
RGD |
PMID:20199183 PMID:20551628 PMID:22031851 |
RGD:6907070 RGD:7175302 RGD:7175346 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility disease_progression |
ISO |
DNA:polymorphism:intron:IVS6+327A>G rs452204 (human) DNA:repeats:intron:IVS2+914_1000dup IL1RN*1 (human) DNA:polymorphism:exon:g.14709C>T rs315952 (human) DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) protein:increased expression:serum (human) |
RGD |
PMID:12837270 PMID:16556139 PMID:16766392 PMID:17224277 PMID:20551628 |
RGD:6907070 RGD:6907105 RGD:6907131 RGD:6907368 RGD:6907370 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il20 |
interleukin 20 |
|
ISO |
protein:increased expression:multiple organs protein:increased expression:serum |
RGD |
PMID:18639518 |
RGD:5147394 |
NCBI chrNW_004955406:42,398,510...42,401,561
Ensembl chrNW_004955406:42,398,782...42,401,490
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19539174 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
ISO |
protein:decreased tyrosine phosphorylation:aorta |
RGD |
PMID:22942179 |
RGD:7207055 |
NCBI chrNW_004955453:7,685,715...7,742,262
Ensembl chrNW_004955453:7,685,715...7,742,262
|
|
G |
Itga8 |
integrin subunit alpha 8 |
|
ISO |
associated with Polycystic Kidney, Autosomal Dominant;DNA:polymorphism: :-414T>C(human) |
RGD |
PMID:18277079 |
RGD:7257723 |
NCBI chrNW_004955429:11,932,764...12,120,757
Ensembl chrNW_004955429:11,932,570...12,120,821
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
associated with Hypertension;DNA:polymorphism |
RGD |
PMID:19368146 |
RGD:6907396 |
NCBI chrNW_004955478:9,788,192...9,830,254
Ensembl chrNW_004955478:9,788,149...9,823,746
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:increased expression:renal cortex, cytosol (rat) |
RGD |
PMID:20007347 |
RGD:6892947 |
NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290
|
|
G |
Kl |
klotho |
|
ISO |
mRNA:decreased expression:kidney: mRNA,protein:decreased expression:kidney: |
RGD |
PMID:9731228 PMID:11162628 |
RGD:10403042 RGD:10403067 |
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
|
RGD |
PMID:11849458 |
RGD:1581753 |
NCBI chrNW_004955559:457,030...461,086
Ensembl chrNW_004955559:456,932...465,704
|
|
G |
Lcat |
lecithin-cholesterol acyltransferase |
|
ISO |
|
RGD |
PMID:15280162 |
RGD:1581769 |
NCBI chrNW_004955484:8,772,692...8,776,122
Ensembl chrNW_004955484:8,772,692...8,776,122
|
|
G |
Lep |
leptin |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:9294834 |
RGD:10053636 |
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
|
|
G |
Lipc |
lipase C, hepatic type |
|
ISO |
protein, mRNA:decreased expression:hepatocytes, liver (rat) |
RGD |
PMID:8636395 |
RGD:2308788 |
NCBI chrNW_004955450:15,947,869...16,062,449
Ensembl chrNW_004955450:15,948,187...16,048,766
|
|
G |
Lipj |
lipase family member J |
|
ISO |
ClinVar Annotator: match by term: Stage 5 chronic kidney disease |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955425:4,337,718...4,368,577
Ensembl chrNW_004955425:4,337,718...4,365,841
|
|
G |
LOC102004641 |
cytochrome b-245 light chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19420110 |
RGD:2306994 |
NCBI chrNW_004955541:2,570,843...2,573,822
Ensembl chrNW_004955541:2,569,727...2,574,118
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
DNA:polymorphisms:exon, 3' utr:3801T>C (rs4646903), p.I462V (rs1048943) (human) mRNA, protein:decreased expression:intestine |
RGD |
PMID:12039987 PMID:23619522 |
RGD:7257728 RGD:7296923 |
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
LOC102012042 |
cytochrome b-245 heavy chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15550752 PMID:19420110 |
RGD:1599682 |
NCBI chrNW_004955587:781,533...818,149
Ensembl chrNW_004955587:781,388...819,912
|
|
G |
Lpin1 |
lipin 1 |
|
ISO |
mRNA:increased expression:skeletal muscle |
RGD |
PMID:14718385 |
RGD:1641826 |
NCBI chrNW_004955487:6,139,188...6,207,316
Ensembl chrNW_004955487:6,138,926...6,210,012
|
|
G |
Lpl |
lipoprotein lipase |
|
ISO |
|
RGD |
PMID:22009636 |
RGD:6909179 |
NCBI chrNW_004955403:43,646,084...43,672,116
Ensembl chrNW_004955403:43,646,084...43,673,967
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:15266031 |
RGD:1641836 |
NCBI chrNW_004955449:5,155,109...5,314,886
Ensembl chrNW_004955449:5,160,946...5,314,948
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
associated with Lupus Erythematosus, Systemic;DNA:polymorphisms |
RGD |
PMID:16801331 |
RGD:6903261 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Mlxipl |
MLX interacting protein like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955456:14,096,530...14,116,687
Ensembl chrNW_004955456:14,096,531...14,117,269
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
|
ISO |
associated with Hypertension; protein:increased expression:plasma (human) |
RGD |
PMID:19886850 |
RGD:7207051 |
NCBI chrNW_004955412:5,965,388...5,976,353
Ensembl chrNW_004955412:5,965,394...5,976,382
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
associated with Hypertension; protein:increased expression:plasma (human) |
RGD |
PMID:19886850 |
RGD:7207051 |
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mpo |
myeloperoxidase |
disease_progression |
ISO |
|
RGD |
PMID:20638167 |
RGD:6909184 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Msr1 |
macrophage scavenger receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955463:1,197,086...1,263,943
Ensembl chrNW_004955463:1,197,022...1,264,765
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility no_association severity |
ISO |
DNA:transition, transversion:cds:g.677C>T, g.1298A>C (human) DNA:SNP: :677C>T(human) DNA:transition:cds:g.677C>T (human) associated with Diabetes Mellitus, Type 2; DNA:transition:cds:g.677C>T (human) DNA:transitions, transversion, haplotype:cds:g.677C>T, g.1298A>C, g.1793G>A (human) |
RGD |
PMID:14737040 PMID:17899317 PMID:19520069 PMID:19520684 PMID:25664255 |
RGD:14696732 RGD:6893522 RGD:6893523 RGD:6893524 RGD:6893579 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:22427849 |
RGD:10040968 |
NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694
|
|
G |
Myh9 |
myosin heavy chain 9 |
|
ISO |
associated with hypertension, glomerulosclerosis, focal segmental;DNA:SNPs: :rs4821480, rs2032487, rs4821481(human) associated with hypertension;DNA:polymorphisms:multiple: DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism associated with diabetes mellitus,type 2;DNA:SNPs: : associated with diabetes mellitus, type 2;DNA:SNPs: : |
RGD CTD |
PMID:18794854 PMID:18794856 PMID:19177153 PMID:19567477 PMID:20144966 PMID:21968013 More...
|
RGD:6903237 RGD:6903238 RGD:6903239 RGD:6903243 RGD:6903256 |
NCBI chrNW_004955413:22,881,759...22,972,182
Ensembl chrNW_004955413:22,881,045...22,972,450
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19420110 |
|
NCBI chrNW_004955456:13,353,780...13,363,956
Ensembl chrNW_004955456:13,354,011...13,363,891
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19420110 |
|
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
|
|
G |
Ngf |
nerve growth factor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19169037 PMID:24244623 |
RGD:7242783 |
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
|
|
G |
Nos1 |
nitric oxide synthase 1 |
treatment |
ISO |
protein:decreased expression:kidney cortex |
RGD |
PMID:17200156 PMID:23185775 |
RGD:1642147 RGD:7257669 |
NCBI chrNW_004955455:13,797,557...13,978,402
Ensembl chrNW_004955455:13,797,545...13,972,566
|
|
G |
Nos3 |
nitric oxide synthase 3 |
susceptibility |
ISO |
DNA:duplication, snp:intron, cds:g.IVS4?-?+27, p.E298D (human) protein:decreased expression:glomerulus |
RGD |
PMID:12701818 PMID:18089446 |
RGD:2292109 RGD:7777097 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19420110 |
|
NCBI chrNW_004955414:4,062,337...4,220,032
Ensembl chrNW_004955414:4,062,081...4,212,746
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
disease_progression |
ISO |
mRNA;increased expression:urine (rat) |
RGD |
PMID:19389856 |
RGD:38599006 |
NCBI chrNW_004955468:2,715,728...2,734,174
Ensembl chrNW_004955468:2,714,419...2,734,830
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:7606877 |
RGD:7246912 |
NCBI chrNW_004955486:2,054,775...2,056,130
|
|
G |
Nppc |
natriuretic peptide C |
|
ISO |
protein:increased expression:plasma protein:increased expression:plasma (human) |
RGD |
PMID:8117275 PMID:8743538 |
RGD:1580770 RGD:1642297 |
NCBI chrNW_004955453:3,884,580...3,888,494
Ensembl chrNW_004955453:3,884,560...3,888,850
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
|
RGD |
PMID:18591458 |
RGD:7174716 |
NCBI chrNW_004955415:10,494,704...10,585,778
Ensembl chrNW_004955415:10,494,640...10,586,221
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16631587 |
|
NCBI chrNW_004955485:9,351,913...9,430,607
Ensembl chrNW_004955485:9,350,087...9,430,607
|
|
G |
Pgf |
placental growth factor |
|
ISO |
|
RGD |
PMID:16543713 |
RGD:1642390 |
NCBI chrNW_004955523:616,196...627,055
Ensembl chrNW_004955523:616,154...627,713
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Stage 5 chronic kidney disease |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
plasma:increased expression:plasma |
RGD |
PMID:16421163 |
RGD:7248787 |
NCBI chrNW_004955437:11,534,251...11,577,942
Ensembl chrNW_004955437:11,534,173...11,555,996
|
|
G |
Plau |
plasminogen activator, urokinase |
severity treatment |
ISO |
protein:increased expression, increased activity:kidney (rat) protein:increased expression:plasma (human) |
RGD |
PMID:15506291 PMID:17869326 PMID:19926968 PMID:22683425 |
RGD:6483806 RGD:7241081 RGD:7241218 RGD:7241279 |
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:19926968 |
RGD:6483806 |
NCBI chrNW_004955555:1,378,505...1,393,395
Ensembl chrNW_004955555:1,378,793...1,393,324
|
|
G |
Postn |
periostin |
|
ISO |
mRNA,protein:increased expression,increased secretion:kidney,urine: |
RGD |
PMID:22167593 |
RGD:10040972 |
NCBI chrNW_004955431:8,510,646...8,544,901
Ensembl chrNW_004955431:8,510,624...8,544,971
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
disease_progression |
ISO |
associated with Diabetes Mellitus, Insulin-Dependent;DNA:SNP: :p.P12A (human) |
RGD |
PMID:18467141 |
RGD:2301857 |
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
ISO |
|
RGD |
PMID:16871242 |
RGD:10003092 |
NCBI chrNW_004955426:24,997,811...25,010,822
Ensembl chrNW_004955426:24,997,811...25,010,822
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19420110 |
|
NCBI chrNW_004955419:5,678,750...5,699,305
Ensembl chrNW_004955419:5,678,694...5,699,305
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19420110 |
|
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Pth |
parathyroid hormone |
severity |
ISO |
protein:increased expression:serum (human) protein:increased expression:serum (rat) |
RGD |
PMID:23243213 PMID:23548814 |
RGD:7242564 RGD:7242692 |
NCBI chrNW_004955414:28,828,389...28,831,417
Ensembl chrNW_004955414:28,825,651...28,831,117
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:kidney |
CTD RGD |
PMID:18077597 PMID:19420110 |
RGD:2298859 |
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
|
|
G |
Retn |
resistin |
severity |
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19539174 PMID:22421264 |
RGD:7207074 |
NCBI chrNW_004955563:1,607,814...1,609,273
Ensembl chrNW_004955563:1,607,814...1,609,273
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
ClinVar Annotator: match by term: Stage 5 chronic kidney disease |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955425:4,368,620...4,667,947
|
|
G |
Scarb1 |
scavenger receptor class B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955482:4,813,502...4,836,479
Ensembl chrNW_004955482:4,813,955...4,837,392
|
|
G |
Sell |
selectin L |
no_association |
ISO |
|
RGD |
PMID:22119815 |
RGD:7175303 |
NCBI chrNW_004955462:7,591,997...7,611,408
Ensembl chrNW_004955462:7,591,366...7,612,846
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19420110 PMID:26903149 |
RGD:11073683 |
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
protein:decreased expression:kidney, plasma membrane |
RGD |
PMID:12110012 PMID:23280877 |
RGD:7243177 RGD:7243883 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
mRNA:decreased expression:renal cortex (rat) |
RGD |
PMID:15452708 |
RGD:7242930 |
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
|
|
G |
Slc9a5 |
solute carrier family 9 member A5 |
resistance |
ISO |
DNA:polymorphism |
RGD |
PMID:10642288 |
RGD:1643221 |
NCBI chrNW_004955484:9,359,468...9,379,959
Ensembl chrNW_004955484:9,359,468...9,379,697
|
|
G |
Soat2 |
sterol O-acyltransferase 2 |
|
ISO |
|
RGD |
PMID:12217884 |
RGD:625687 |
NCBI chrNW_004955458:383,123...394,003
Ensembl chrNW_004955458:382,892...394,749
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19878707 |
|
NCBI chrNW_004955577:171,425...183,669
Ensembl chrNW_004955577:171,425...186,046
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver |
CTD RGD |
PMID:16814791 PMID:19878707 |
RGD:2308825 |
NCBI chrNW_004955413:27,271,717...27,326,655
Ensembl chrNW_004955413:27,271,953...27,326,759
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26970513 |
|
NCBI chrNW_004955451:13,315,237...13,317,888
Ensembl chrNW_004955451:13,315,859...13,325,937
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:kidney |
CTD RGD |
PMID:10919844 PMID:19420110 |
RGD:7394838 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:21873362 PMID:22129968 |
RGD:5684979 RGD:5684981 |
NCBI chrNW_004955415:30,222,830...30,226,406
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:20729266 |
RGD:7240546 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:20729266 |
RGD:7240546 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19539174 PMID:22266663 |
RGD:7245510 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11b |
severity |
ISO |
|
RGD |
PMID:21479768 |
RGD:7205485 |
NCBI chrNW_004955417:24,804,708...24,831,338
Ensembl chrNW_004955417:24,804,664...24,831,894
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma |
RGD |
PMID:22266663 |
RGD:7245510 |
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma |
RGD |
PMID:22266663 |
RGD:7245510 |
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
|
|
G |
Ucp2 |
uncoupling protein 2 |
susceptibility |
ISO |
DNA:polymorphism: :-866G>A (human) DNA:deletion |
RGD |
PMID:18242170 PMID:19406964 |
RGD:7175298 RGD:7175299 |
NCBI chrNW_004955414:17,592,914...17,596,477
Ensembl chrNW_004955414:17,592,914...17,596,477
|
|
G |
Vwf |
von Willebrand factor |
treatment disease_progression |
ISO |
protein:increased oxidation:plasma |
RGD |
PMID:21378155 PMID:22091998 PMID:22189209 |
RGD:7205641 RGD:7205646 RGD:7205649 |
NCBI chrNW_004955413:3,672,470...3,825,588
Ensembl chrNW_004955413:3,672,470...3,819,571
|
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Frasier syndrome |
OMIM ClinVar |
PMID:1302008 PMID:1658787 PMID:7795587 PMID:8388765 PMID:9108089 PMID:9398852 PMID:9499425 PMID:9529364 PMID:9531607 PMID:9536098 PMID:10094551 PMID:10571943 PMID:10762296 PMID:11241055 PMID:11738793 PMID:12050205 PMID:12471221 PMID:15150775 PMID:15266301 PMID:15483024 PMID:17576681 PMID:17694336 PMID:18559874 PMID:18591546 PMID:18618575 PMID:19171881 PMID:19205749 PMID:19221039 PMID:19484379 PMID:19494353 PMID:19536888 PMID:20368469 PMID:20413658 PMID:20435628 PMID:20442690 PMID:20595692 PMID:21499692 PMID:21504297 PMID:21508141 PMID:21851196 PMID:22099579 PMID:23117548 PMID:23295293 PMID:23349334 PMID:23515051 PMID:24033266 PMID:24161391 PMID:24856380 PMID:25110071 PMID:25741868 PMID:25818337 PMID:25932436 PMID:26358501 PMID:26467025 PMID:26725263 PMID:27719739 PMID:28204945 PMID:28492532 PMID:28780565 PMID:29668062 PMID:30406062 PMID:30655312 PMID:32352694 PMID:32581362 More...
|
|
NCBI chrNW_004955476:10,464,688...10,504,473
Ensembl chrNW_004955476:10,464,616...10,504,473
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6734075 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:16197457 |
RGD:6893534 |
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
|
|
G |
Cd46 |
CD46 molecule |
susceptibility |
ISO |
DNA:mutations:multiple (human) DNA:deletion, missense mutation:cds:p.D237_S238del, p.S206P (human) DNA:frameshift mutation:cds:p.N233X3 (human) |
RGD |
PMID:14566051 PMID:14615110 PMID:16189652 |
RGD:11352767 RGD:11352770 RGD:11531138 |
NCBI chrNW_004955406:43,002,817...43,034,555
|
|
G |
Dgke |
diacylglycerol kinase epsilon |
|
ISO |
ClinVar Annotator: match by term: Hemolytic-uremic syndrome |
ClinVar |
PMID:25854283 |
|
NCBI chrNW_004955451:5,966,773...5,988,004
Ensembl chrNW_004955451:5,969,070...5,988,004
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12053072 |
|
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
associated with diarrhea;protein:increased expression:plasma (human) |
RGD |
PMID:9423793 |
RGD:40818428 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:15632024 |
RGD:7242276 |
NCBI chrNW_004955523:307,181...310,728
Ensembl chrNW_004955523:305,728...310,728
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15384034 |
|
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15384034 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
severity |
ISO |
associated with Escherichia Coli Infections; |
RGD |
PMID:30467800 |
RGD:39458200 |
NCBI chrNW_004955470:7,779,828...7,849,157
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased concentration:serum (human) |
RGD |
PMID:9802632 PMID:12373296 |
RGD:6909134 RGD:6909171 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15384034 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Mbl2 |
mannose binding lectin 2 |
treatment |
ISO |
|
RGD |
PMID:27378476 |
RGD:11530050 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12588957 |
|
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
severity |
ISO |
associated with Escherichia coli Infections; DNA:transversion mutation: :994 G>T (human) |
RGD |
PMID:10873870 |
RGD:7257516 |
NCBI chrNW_004955437:11,534,251...11,577,942
Ensembl chrNW_004955437:11,534,173...11,555,996
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
associated with Escherichia coli Infections;protein:increased expression:plasma (human) |
RGD |
PMID:11777999 |
RGD:11541069 |
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:22942429 |
RGD:11038690 |
NCBI chrNW_004955415:30,222,830...30,226,406
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15384034 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7967349 |
|
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21253390 |
|
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
|
RGD |
PMID:15531919 |
RGD:1581228 |
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:18093430 |
RGD:4144102 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:18093430 |
RGD:4144102 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
|
G |
Sars2 |
seryl-tRNA synthetase 2, mitochondrial |
|
ISO |
ClinVar Annotator: match by term: HUPRA SYNDROME | ClinVar Annotator: match by term: HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME |
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:21255763 PMID:24034276 PMID:25741868 PMID:27279129 PMID:28492532 PMID:31607746 More...
|
|
NCBI chrNW_004955468:603,778...613,475
Ensembl chrNW_004955468:603,778...613,475
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chrNW_004955519:2,591,229...2,643,705
Ensembl chrNW_004955519:2,591,248...2,633,495
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
ISO |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chrNW_004955487:5,180,241...5,218,298
Ensembl chrNW_004955487:5,180,252...5,218,216
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
ISO |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chrNW_004955403:50,046,262...50,115,004
Ensembl chrNW_004955403:50,046,004...50,117,201
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
ISO |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chrNW_004955407:26,524,487...26,533,038
Ensembl chrNW_004955407:26,524,130...26,533,038
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296 |
RGD:7364948 |
NCBI chrNW_004955414:25,951,473...25,953,593
Ensembl chrNW_004955414:25,951,349...25,953,645
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chrNW_004955464:12,715,238...12,729,034
Ensembl chrNW_004955464:12,714,717...12,729,662
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chrNW_004955512:5,686,508...5,703,645
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chrNW_004955428:18,873,782...18,907,955
Ensembl chrNW_004955428:18,873,782...18,907,955
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
ISO |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chrNW_004955405:34,619,780...34,693,616
Ensembl chrNW_004955405:34,623,267...34,693,677
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:13792599 RGD:2293026 |
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chrNW_004955438:16,500,219...16,505,394
Ensembl chrNW_004955438:16,500,633...16,501,691
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chrNW_004955451:16,616,595...16,625,731
Ensembl chrNW_004955451:16,616,595...16,625,730
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chrNW_004955477:9,621,812...9,630,406
Ensembl chrNW_004955477:9,621,812...9,638,099
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004955403:24,315,712...24,326,271
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chrNW_004955431:18,685,408...18,723,221
Ensembl chrNW_004955431:18,686,190...18,723,524
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:12538716 PMID:16467447 |
RGD:7242709 RGD:7242734 |
NCBI chrNW_004955437:461,235...466,908
Ensembl chrNW_004955437:461,235...470,464
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
|
ISO |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chrNW_004955442:7,600,903...7,647,619
Ensembl chrNW_004955442:7,603,893...7,647,624
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:19196448 PMID:23143303 |
RGD:7257565 RGD:7257570 |
NCBI chrNW_004955435:13,404,236...13,423,059
Ensembl chrNW_004955435:13,404,508...13,424,247
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
|
RGD |
PMID:9407517 PMID:22189844 |
RGD:7204675 RGD:7204727 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chrNW_004955440:3,456,165...3,460,024
Ensembl chrNW_004955440:3,455,153...3,460,109
|
|
G |
Daxx |
death domain associated protein |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747 |
RGD:9587836 |
NCBI chrNW_004955437:1,869,692...1,874,041
Ensembl chrNW_004955437:1,869,572...1,873,050
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31383731 |
RGD:151347540 |
NCBI chrNW_004955583:820,893...838,515
Ensembl chrNW_004955583:820,931...841,654
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chrNW_004955418:29,274,170...29,283,028
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
ISO |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chrNW_004955427:14,219,519...14,252,178
Ensembl chrNW_004955427:14,219,594...14,252,178
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004955492:7,407,800...7,454,851
Ensembl chrNW_004955492:7,407,800...7,454,842
|
|
G |
Egln3 |
egl-9 family hypoxia inducible factor 3 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004955409:26,939,933...26,967,156
Ensembl chrNW_004955409:26,939,933...26,967,156
|
|
G |
Eng |
endoglin |
|
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653 |
RGD:7248779 |
NCBI chrNW_004955419:818,797...853,319
Ensembl chrNW_004955419:818,932...852,694
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chrNW_004955413:26,647,553...26,727,875
Ensembl chrNW_004955413:26,648,339...26,727,933
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077 RGD:11041698 |
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chrNW_004955423:254,060...264,448
Ensembl chrNW_004955423:254,189...264,159
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004955471:8,824,901...8,832,836
Ensembl chrNW_004955471:8,822,965...8,832,884
|
|
G |
Fgg |
fibrinogen gamma chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004955471:8,786,910...8,794,947
Ensembl chrNW_004955471:8,786,910...8,795,013
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chrNW_004955457:629,599...694,948
Ensembl chrNW_004955457:629,518...696,975
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chrNW_004955523:307,181...310,728
Ensembl chrNW_004955523:305,728...310,728
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418 |
RGD:9685723 |
NCBI chrNW_004955442:15,280,753...15,283,405
Ensembl chrNW_004955442:15,281,419...15,283,266
|
|
G |
Glo1 |
glyoxalase I |
|
ISO |
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chrNW_004955437:4,728,709...4,749,834
Ensembl chrNW_004955437:4,728,709...4,749,834
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004955558:826,853...836,809
Ensembl chrNW_004955558:826,853...836,809
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004955540:593,316...609,760
Ensembl chrNW_004955540:593,316...609,865
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23019274 PMID:23085062 PMID:23552495 |
RGD:7244372 RGD:7245489 RGD:7245495 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment severity |
ISO |
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334 RGD:9068883 |
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chrNW_004955454:2,907,265...2,932,352
Ensembl chrNW_004955454:2,907,265...2,932,351
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
|
|
G |
Hyal1 |
hyaluronidase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004955532:2,113,016...2,116,093
Ensembl chrNW_004955532:2,112,771...2,115,952
|
|
G |
Hyal2 |
hyaluronidase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004955532:2,120,781...2,125,083
Ensembl chrNW_004955532:2,120,781...2,123,726
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chrNW_004955536:611,965...658,647
Ensembl chrNW_004955536:612,774...658,647
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:14975137 RGD:7364864 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20030532 |
RGD:7175501 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
mouse model treated with human protein rat model treated with human protein |
RGD |
PMID:9555664 PMID:16849996 PMID:18363573 |
RGD:6907101 RGD:6907359 RGD:6909149 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
Associated with renal transplant patients |
RGD |
PMID:11007822 PMID:20504838 |
RGD:6907049 RGD:6907073 |
NCBI chrNW_004955407:41,779,849...41,805,637
Ensembl chrNW_004955407:41,777,777...41,800,201
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chrNW_004955414:32,209,426...32,212,424
Ensembl chrNW_004955414:32,210,545...32,211,717
|
|
G |
Kl |
klotho |
treatment |
ISO |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278 |
RGD:10403064 |
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
|
|
G |
Lep |
leptin |
resistance |
ISO |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
|
|
G |
LOC102021597 |
alpha-1-antiproteinase S-like |
treatment |
ISO |
|
RGD |
PMID:28235038 |
RGD:14695051 |
NCBI chrNW_004955438:17,920,200...17,929,105
|
|
G |
LOC102023780 |
aromatase |
treatment |
ISO |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chrNW_004955409:3,198,622...3,313,072
Ensembl chrNW_004955409:3,266,233...3,313,142
|
|
G |
LOC102025775 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chrNW_004955412:20,203,173...20,204,714
Ensembl chrNW_004955412:20,203,772...20,204,203
|
|
G |
Map1lc3a |
microtubule associated protein 1 light chain 3 alpha |
treatment |
ISO |
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916 RGD:11561958 |
NCBI chrNW_004955422:26,774,466...26,776,024
Ensembl chrNW_004955422:26,774,922...26,775,884
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
ISO |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chrNW_004955439:162,499...376,919
Ensembl chrNW_004955439:163,103...377,808
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:kidney |
RGD |
PMID:18055546 PMID:22950848 |
RGD:6909167 RGD:7174699 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Muc1 |
mucin 1, cell surface associated |
treatment |
ISO |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
|
RGD |
PMID:22160772 PMID:24096033 |
RGD:13801197 RGD:13801199 |
NCBI chrNW_004955485:9,607,781...9,613,123
Ensembl chrNW_004955485:9,607,781...9,613,151
|
|
G |
Nes |
nestin |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chrNW_004955545:2,748,132...2,756,595
Ensembl chrNW_004955545:2,748,078...2,756,301
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:29291552 |
RGD:13504682 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chrNW_004955486:2,061,196...2,062,805
Ensembl chrNW_004955486:2,060,735...2,063,003
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4 group A member 1 |
severity |
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:22343121 |
RGD:14700869 |
NCBI chrNW_004955547:2,404,532...2,426,882
Ensembl chrNW_004955547:2,404,532...2,431,050
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chrNW_004955561:1,277,362...1,282,949
Ensembl chrNW_004955561:1,277,365...1,282,793
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chrNW_004955485:9,351,913...9,430,607
Ensembl chrNW_004955485:9,350,087...9,430,607
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004955413:25,150,702...25,166,987
Ensembl chrNW_004955413:25,148,062...25,166,987
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004955447:16,570,652...16,613,410
Ensembl chrNW_004955447:16,569,909...16,612,373
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 PMID:12819032 |
RGD:1580850 RGD:8554477 |
NCBI chrNW_004955415:4,365,848...4,403,317
Ensembl chrNW_004955415:4,365,743...4,403,587
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chrNW_004955474:1,831,221...1,868,170
Ensembl chrNW_004955474:1,833,701...1,868,817
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chrNW_004955480:543,397...1,188,376
Ensembl chrNW_004955480:1,078,322...1,188,435
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
|
RGD |
PMID:23393318 |
RGD:7327166 |
NCBI chrNW_004955425:4,368,620...4,667,947
|
|
G |
Serpinc1 |
serpin family C member 1 |
severity |
ISO |
|
RGD |
PMID:26108065 |
RGD:11354006 |
NCBI chrNW_004955406:14,024,183...14,036,206
Ensembl chrNW_004955406:14,024,313...14,035,948
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chrNW_004955491:8,647,133...8,657,381
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chrNW_004955425:20,280,725...20,307,663
Ensembl chrNW_004955425:20,279,963...20,307,663
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chrNW_004955445:19,213,210...19,227,670
Ensembl chrNW_004955445:19,215,161...19,228,695
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
ISO |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chrNW_004955458:4,833,417...4,847,956
Ensembl chrNW_004955458:4,833,515...4,843,273
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chrNW_004955403:10,925,155...11,004,229
Ensembl chrNW_004955403:10,924,893...11,004,284
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment severity |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 PMID:23239000 |
RGD:7207892 RGD:7207894 RGD:7207896 RGD:7240552 RGD:7241087 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:23239000 |
RGD:7207892 RGD:7240552 RGD:7241087 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19925291 |
RGD:2315112 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chrNW_004955413:3,672,470...3,825,588
Ensembl chrNW_004955413:3,672,470...3,819,571
|
|
|
G |
Scarb2 |
scavenger receptor class B member 2 |
|
ISO |
ClinVar Annotator: match by term: Action myoclonus-renal failure syndrome | ClinVar Annotator: match by term: Epilepsy, progressive myoclonic 4, with or without renal failure |
OMIM ClinVar |
PMID:9536098 PMID:15364701 PMID:17576681 PMID:18308289 PMID:18424452 PMID:19454373 PMID:19597094 PMID:19847901 PMID:21670406 PMID:21796727 PMID:22032306 PMID:22767442 PMID:23225201 PMID:23515316 PMID:23659519 PMID:24339182 PMID:24485911 PMID:24620919 PMID:25088547 PMID:25741868 PMID:26467025 PMID:26836416 PMID:28492532 PMID:29261713 PMID:29358611 More...
|
|
NCBI chrNW_004955433:884,740...962,932
Ensembl chrNW_004955433:884,740...962,932
|
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
ClinVar Annotator: match by term: Papillorenal syndrome with macular abnormalities | ClinVar Annotator: match by term: Renal coloboma syndrome |
OMIM ClinVar |
PMID:2644560 PMID:3377002 PMID:7795640 PMID:8589702 PMID:8943028 PMID:9106533 PMID:9536098 PMID:9760197 PMID:10466411 PMID:10533062 PMID:11093271 PMID:11241473 PMID:11461952 PMID:15652857 PMID:17576681 PMID:20221250 PMID:21654726 PMID:22213154 PMID:23539225 PMID:24429398 PMID:24676634 PMID:25640679 PMID:25741868 PMID:27226968 PMID:27657687 PMID:28041643 PMID:28166811 PMID:28492532 PMID:29054766 PMID:29973660 PMID:30076350 PMID:30241513 PMID:30773290 PMID:31001663 PMID:31060108 PMID:31576025 PMID:31692565 PMID:32203253 PMID:33532864 More...
|
|
NCBI chrNW_004955485:9,351,913...9,430,607
Ensembl chrNW_004955485:9,350,087...9,430,607
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
protein:increased expression:peritoneal cavity lining |
RGD |
PMID:16757496 |
RGD:1625341 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
ISO |
|
RGD |
PMID:807434 |
RGD:1598784 |
NCBI chrNW_004955435:4,622,142...4,684,439
Ensembl chrNW_004955435:4,621,991...4,688,139
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
|
ISO |
protein:increased expression:aorta |
RGD |
PMID:18288101 |
RGD:2315619 |
NCBI chrNW_004955452:1,820,212...1,873,877
Ensembl chrNW_004955452:1,820,174...1,874,226
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
mRNA:increased expression:omentum (rat) |
RGD |
PMID:18751736 |
RGD:2314180 |
NCBI chrNW_004955403:54,139,823...54,193,740
Ensembl chrNW_004955403:54,139,823...54,195,032
|
|
G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
|
ISO |
|
RGD |
PMID:7933831 |
RGD:1300446 |
NCBI chrNW_004955419:26,801,924...26,852,116
Ensembl chrNW_004955419:26,801,925...26,851,627
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19092814 |
|
NCBI chrNW_004955415:17,048,374...17,058,172
Ensembl chrNW_004955415:17,048,030...17,060,181
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
protein:increased activity:erythrocyte |
RGD |
PMID:7437264 |
RGD:8662343 |
NCBI chrNW_004955442:18,130,282...18,152,153
Ensembl chrNW_004955442:18,130,987...18,137,412
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
protein:increased expression:plasma (rat) |
RGD |
PMID:11518857 |
RGD:8662310 |
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12675867 |
|
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
|
ISO |
|
RGD |
PMID:19339809 |
RGD:10044236 |
NCBI chrNW_004955413:2,182,459...2,192,279
Ensembl chrNW_004955413:2,182,459...2,192,279
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19092814 |
|
NCBI chrNW_004955497:7,653,309...7,831,737
Ensembl chrNW_004955497:7,653,248...7,831,472
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
treatment |
ISO |
|
RGD |
PMID:16291838 |
RGD:10042968 |
NCBI chrNW_004955433:6,452,931...6,470,209
Ensembl chrNW_004955433:6,454,454...6,469,904
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17347482 |
|
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19092814 |
|
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
|
|
G |
Mgp |
matrix Gla protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19092814 |
|
NCBI chrNW_004955413:11,614,851...11,618,090
Ensembl chrNW_004955413:11,615,078...11,618,024
|
|
G |
Mstn |
myostatin |
|
ISO |
associated with Kidney Failure, Chronic |
RGD |
PMID:16871256 |
RGD:2303558 |
NCBI chrNW_004955403:8,914,505...8,921,190
Ensembl chrNW_004955403:8,914,482...8,923,465
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:21957179 |
RGD:5508758 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
|
|